var  groupallo = {
    "feature_count": 1018,
    "type": [
        "FeatureCollection"
    ],
    "features": [
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions",
                "aff": "Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04684602",
                "enrolled": 5000,
                "radius": 80,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 102, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12920,
                "paneLabel": "pane12920",
                "start": "2020-07-09",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.396466,
                    34.0211224
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10757 - Cardiology, P.C., Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.8024326,
                    33.5206824
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13262 - University of Alabama at Birmingham Hospital, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.8024326,
                    33.5206824
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10779 - Mercy Gilbert Medical Center, Gilbert, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111.7890373,
                    33.3527632
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10786 - Cardiovascular Associates of Mesa, Mesa, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111.8314792,
                    33.4151117
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10756 - Mayo Clinic, Phoenix, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -112.074141,
                    33.4484367
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13023 - University of Arizona Medical Center, Tucson, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -110.9748477,
                    32.2228765
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10754 - University of California, San Diego, La Jolla, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.23112468377349,
                    32.87924375
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10759 - Scripps Clinic, La Jolla, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.2740777,
                    32.8401623
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13265 - University of California, Los Angeles, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.242766,
                    34.0536909
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10775 - Cedars-Sinai Medical Care Foundation, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.242766,
                    34.0536909
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10778 - Orange County Cardiology, Orange, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.8704931,
                    33.7500378
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13031 - St. John's Regional Medical Center, Oxnard, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -119.1803818,
                    34.1976308
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13275 - Stanford University Hospital, Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.17030545534064,
                    37.4265407
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13267 - Bethesda Heart Hospital, Boynton Beach, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.0666026,
                    26.5256179
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10780 - Morton Plant Hospital, Clearwater, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.8001026,
                    27.9658533
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10760 - Shands Hospital, University of Florida, Gainesville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.34901329340119,
                    29.6328784
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13273 - University of Florida Health, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.655651,
                    30.3321838
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10768 - University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13280, Orlando, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.3790304,
                    28.5421109
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13264 - Florida Hospital Pepin Heart Institute, Tampa, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.458444,
                    27.9477595
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13027 - Emory University School of Medicine, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.3902644,
                    33.7489924
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10765 - Georgia Regents University, Augusta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.9748429,
                    33.4709714
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10772 - University Cardiologist, Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.66910060446992,
                    41.87352605
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13030 - University of Iowa, Iowa City, Iowa, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91.5299106,
                    41.6612561
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10783 - Gill Heart Institute, University of Kentucky, Lexington, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.5048374161113,
                    38.027038
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13022 - University of Louisville, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85.759407,
                    38.2542376
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13266, New Orleans, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.0782127,
                    29.9759983
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10782, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.060511,
                    42.3554334
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10766 - Michigan Cardiovascular Institute, Saginaw, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.9490365,
                    43.4200387
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10762 - Minneapolis Heart Institute, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93.2654692,
                    44.9772995
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10761 - Mayo Clinic, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92.4630182,
                    44.0234387
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13281, Las Vegas, Nevada, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.148516,
                    36.1672559
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13263 - RWJ Barnabas Heart Center, Newark, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74.1723667,
                    40.735657
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10776 - Columbia University Medical Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13026 - Sanger Heart and Vascular Institute, Carolinas Healthcare System, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.74737175036097,
                    35.3057976
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10781 - Duke University, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.9018053,
                    35.996653
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10758 - The Christ Hospital, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.5124602,
                    39.1014537
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10770 - University of Cincinnati, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.5124602,
                    39.1014537
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10773, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.6936813,
                    41.4996562
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13278 - OhioHealth Research Institute, Columbus, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.0007065,
                    39.9622601
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10785 - Lehigh Valley Hospital, Allentown, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.4712794,
                    40.6022059
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13261 - University of Pennsylvania, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.1635262,
                    39.9527237
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10767 - Temple University Hospital, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.1635262,
                    39.9527237
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13277, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.1635262,
                    39.9527237
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10774 - University of Pittsburgh, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.6243098,
                    40.3693889
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10777 - Stern Cardiovascular Foundation, Germantown, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89.8100858,
                    35.0867577
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13024 - Austin Heart, PLLC, Austin, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97.8267724,
                    30.3068274
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13274 - Soltero CV Research Center, Baylor Scott & White Research Institute, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.7968559,
                    32.7762719
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10755 - Texas Heart Institute, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.3676974,
                    29.7589382
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13268 - Houston Methodist Hospital, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.3676974,
                    29.7589382
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10763 - University Hospital, Salt Lake City, Utah, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111.8867975,
                    40.7596198
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10771 - Heart & Vascular Research, Swedish Medical Center, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.31090400090532,
                    47.60711215
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10764 - University of Wisconsin, Madison, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89.3837613,
                    43.074761
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10769 - Aurora Healthcare, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.922497,
                    43.0349931
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13279, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.922497,
                    43.0349931
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10789 - Aspirus Research Institute, Wausau, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89.6298239,
                    44.9596017
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 11027, Edmonton, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -113.491241,
                    53.5462055
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 11024 - Victoria Heart Institute Foundation, Victoria, British Columbia, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -123.3649533,
                    48.4283182
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 11025 - St. Michael's Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 70, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.3839347,
                    43.6534817
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)",
                "aff": "Andrews Institute, Gulf Breeze, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818737",
                "enrolled": 480,
                "radius": 31,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 77, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12969,
                "paneLabel": "pane12969",
                "start": "2019-03-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.15941431829276,
                    30.3588342
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)",
                "aff": "The Emory Clinic, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818737",
                "enrolled": 480,
                "radius": 31,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 77, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12969,
                "paneLabel": "pane12969",
                "start": "2019-03-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.3902644,
                    33.7489924
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)",
                "aff": "Duke University, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818737",
                "enrolled": 480,
                "radius": 31,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 77, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12969,
                "paneLabel": "pane12969",
                "start": "2019-03-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.94422972195878,
                    36.00015569999999
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)",
                "aff": "Sanford Health, Fargo, North Dakota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818737",
                "enrolled": 480,
                "radius": 31,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 77, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12969,
                "paneLabel": "pane12969",
                "start": "2019-03-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.79903467206503,
                    46.90020925
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)",
                "aff": "Sanford Health, Sioux Falls, South Dakota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818737",
                "enrolled": 480,
                "radius": 31,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 77, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12969,
                "paneLabel": "pane12969",
                "start": "2019-03-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.72368,
                    43.5499637
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Bone Marrow Mesenchymal Stem Cell Derived EVs for COVID-19 Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS): A Phase III Clinical Trial",
                "aff": "PRX Research, Mesquite, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05354141",
                "enrolled": 400,
                "radius": 30,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 73, 28)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12970,
                "paneLabel": "pane12970",
                "start": "2022-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.599472,
                    32.7666103
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Southern California University Hospital, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.20188823929676,
                    34.0627257
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of California, San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.45825681806237,
                    37.7627257
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Western States Clinical Research, Wheat Ridge, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -105.0772063,
                    39.766098
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Clinical Research of West Florida, Clearwater, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.8001026,
                    27.9658533
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Borland-Groover Clinic, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.655651,
                    30.3321838
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Shafran Gastroenterology Center, Winter Park, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.3510264,
                    28.5977707
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Atlanta Gastroenterology Associates, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.3902644,
                    33.7489924
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Chicago Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.6244212,
                    41.8755616
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Carle Clinic Association, Urbana, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88.207301,
                    40.1117174
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Indiana University Medical Center, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.16382215911352,
                    39.78755735
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Cotton-O'Neil Clinical Research Center, Topeka, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.677556,
                    39.049011
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Kentucky Hospital, Lexington, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.5082097,
                    38.0286002
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Louisville Hospital, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85.74506887135223,
                    38.2483107
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Gulf Coast Research, Baton Rouge, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91.1391153,
                    30.4507936
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Maryland, Baltimore, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.62630185349286,
                    39.289447800000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "National Institutes of Health, Bethesda, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.1040039652674,
                    39.00001425
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Chevy Chase Clinical Research, Chevy Chase, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.0849245,
                    38.9813699
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.06875296664998,
                    42.36286045
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Brigham and Womens Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.060511,
                    42.3554334
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Clinical Pharmacology Study Group, Worcester, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.8018877,
                    42.2625621
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Center for Clinical Studies, Dearborn, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.1763145,
                    42.3222599
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Center for Digestive Health, Troy, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.1499304,
                    42.6055893
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Minnesota Hospital, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93.23144466768856,
                    44.97101265
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "St Louis Center for Clinical Studies, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.2428756,
                    38.6319657
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72.27010183310576,
                    43.67568425
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Weill Cornell Medical College, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.9549121,
                    40.7647523
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Mount Sinai School of Medicine, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Rochester Institute for Digestive Diseases, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.615214,
                    43.157285
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Rochester General Hospital, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.5882888540516,
                    43.1920427
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University Hospital and Medical Center, Stony Brook, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.140943,
                    40.9256538
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Charlotte Gastroenterology and Hepatology, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.8430827,
                    35.2272086
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Pinehurst Medical Clinic, Pinehurst, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.4679317,
                    35.1946235
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Wake Forest University, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.2781152,
                    36.134335
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Gastroenterology United of Tulsa, Tulsa, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.9927436,
                    36.1563122
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Options Health Research, Tulsa, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.9927436,
                    36.1563122
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Allegheney Center for Digestive Health, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.6243098,
                    40.3693889
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Pittsburgh, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.96246095144505,
                    40.44415295
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Gastroenterology Center of the Midsouth, Germantown, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89.8100858,
                    35.0867577
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Nashville GI Specialists, Nashville, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.7742984,
                    36.1622767
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Vanderbilt University Medical Center, Nashville, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.80163418092431,
                    36.14092375
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Baylor University Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.78199034999996,
                    32.7865443
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Texas Medical Branch, Galveston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94.77627329985782,
                    29.31201835
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Texas Health Science Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.4031517,
                    29.7029914
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Vermont, Burlington, Vermont, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.19414679705882,
                    44.4737365
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Digestive and Liver Disease Specialists, Norfolk, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.2602336,
                    36.8968052
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "McGuire Research Institute, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.43428,
                    37.5385087
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Seattle Gastroenterology Associates, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.330062,
                    47.6038321
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Royal Adelaide Hospital, Adelaide, South Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    138.58717276889342,
                    -34.9205767
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Royal Melbourne Hospital, Melbourne, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    144.9564192,
                    -37.7994568
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Calgary, Calgary, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -114.1283072,
                    51.0783651
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Alberta Hospital, Edmonton, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -113.52319456480116,
                    53.5206381
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Health Science Centre, Winnipeg, Manitoba, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97.16277302533985,
                    49.90816975
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "London Health Sciences Centre, London, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.243372,
                    42.9832406
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Mount Sinai Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.39033976650668,
                    43.657443650000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Otago, Christchurch, New Zealand",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    172.6318208,
                    -43.5348592
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Waikato Hospital, Hamilton, New Zealand",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    175.28295759033938,
                    -37.80537155
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis",
                "aff": "Beijing 302 Hospital, Beijing, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT01220492",
                "enrolled": 266,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 89, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2009-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116.3912757,
                    39.906217
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Alabama at Birmingham, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.80604756076488,
                    33.5016153
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Arizona Cancer Center, Tucson, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -110.94208772039823,
                    32.2766429
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "City of Hope, Duarte, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.97324485,
                    34.1276438
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Univeristy of California San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.419906,
                    37.7790262
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Yale New Haven Hospital, New Haven, Connecticut, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72.93559409819855,
                    41.3046035
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.27870688083459,
                    25.71727245
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "All Children's Hospital, Saint Petersburg, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.64059775080256,
                    27.76496205
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Emory University, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.32778960627682,
                    33.795867650000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Northside Hospital, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.35450682100918,
                    33.9102901
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Northwestern Center for Clinical Research, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.6244212,
                    41.8755616
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.66910060446992,
                    41.87352605
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Illinois - Chicago, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.60084387193544,
                    41.79139685
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Indiana Blood and Bone Marrow Transplant Center, Beech Grove, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.0894158,
                    39.7221906
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Univeristy of Iowa Hospitals and Clinics, Iowa City, Iowa, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91.5299106,
                    41.6612561
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Kansas Medical Center, Kansas City, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94.60953952536904,
                    39.05699635
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Louisville, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85.75770751081866,
                    38.21332235
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Louisiana State University, Shreveport, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93.70247014954433,
                    32.4297329
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Maryland/Greenbaum, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.610759,
                    39.2908816
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Tufts-New England Medical Center, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.060511,
                    42.3554334
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.10970567673255,
                    42.33837185
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Dana-Farber Cancer Institute, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.10769331557015,
                    42.33762635
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Karmanos/Wayne State University, Detroit, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.0466403,
                    42.3315509
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Mayo Clinic Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92.466607460917,
                    44.0225389
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Univeristy of Mississippi Medical Center, Jackson, Mississippi, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.1983063,
                    32.3086744
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Nebraska, Omaha, Nebraska, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.0104763,
                    41.257793250000006
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Hackensack University Medical Center, Hackensack, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74.05594087673457,
                    40.8837051
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Roswell Park, Buffalo, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.86568071180923,
                    42.898619800000006
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "New York Presbyterian Hospital, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Mount Sinai Medical Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Columbia University/New York Presbyterian Hospital, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Rochester, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.6307297,
                    43.1226985
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "New York Medical College, Valhalla, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.7751326,
                    41.0748189
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Duke University, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.94422972195878,
                    36.00015569999999
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Wake Forest Univeristy School of Medicine, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.2440518,
                    36.0998131
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Oregon Health and Science University, Portland, Oregon, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.674194,
                    45.5202471
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Penn State Hershey Medical Center, Hershey, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.67321279234645,
                    40.2653862
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Western Pennsylvania Cancer Institute, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.6243098,
                    40.3693889
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.94714193501349,
                    32.7842965
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Texas Cancer Center at Medical City, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.7968559,
                    32.7762719
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Baylor University, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.78199034999996,
                    32.7865443
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Univeristy of Texas Southwestern Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.7968559,
                    32.7762719
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "MD Anderson Cancer Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.39782993506569,
                    29.7076703
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Texas Research Center, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98.58294226252109,
                    29.51447155
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Virginia Commonwealth/Massey Cancer Center, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.43428,
                    37.5385087
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Fred Hutchinson Cancer Research Center, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.33067301841714,
                    47.6277525
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Wisconsin Madison, Madison, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89.43095871991434,
                    43.080274450000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Medical College of Wisconsin, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88.02245316747553,
                    43.04386705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Brisbane Hospital, Herston, Queensland, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    153.02681090546656,
                    -27.4477301
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Melbourne Hospital, Parkville, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    144.9559783,
                    -37.7994515
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Perth Hospital, Perth, Western Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    115.86593154993494,
                    -31.95323205
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Co-Medica Research Network, Calgary, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -114.065465,
                    51.0460954
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "British Columbia's Children's Hospital, Vancouver, British Columbia, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -123.113952,
                    49.2608724
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Cancer Care Manitoba, Winnipeg, Manitoba, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97.15878771446602,
                    49.90309155
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -63.5859487,
                    44.648618
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Hamilton Health Sciences Centre, Hamilton, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.8728583,
                    43.2560802
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "London Health Sciences Centre- Westminster Campus, London, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.243372,
                    42.9832406
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Ottawa Hospital, Ottawa, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.72059219183689,
                    45.39147405
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Toronto General Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.38815803478147,
                    43.6585876
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Princess Margaret Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.39064248533157,
                    43.65816355
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.56227634786634,
                    45.57753825
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Hopital Enfant-Jesus, Quebec, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.22789382663336,
                    46.8386952
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Hopital du Saint-Sacrement, Quebec, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.24626006730523,
                    46.79977065
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Universia degli Studi di Pesaro, Pesaro, PU, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12.9131228,
                    43.9098114
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "IRCCS Policlinico San Matteo, Pavia, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9.137825082826026,
                    45.03685465
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Kantonsspital Basel, Basel, Switzerland",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7.503841,
                    47.424635
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Barts & London School of Medicine, London, England, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -0.0992899692337679,
                    51.522169000000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "John Radcliffe Hospital, Headington, Oxford, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1.2180558792629186,
                    51.76413405
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Bristol Royal Hospital for Children, Bristol, UK, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -2.9937826923778914,
                    51.136471400000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Glasgow Royal Infirmary, Glasgow, UK, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4.2488787,
                    55.8609825
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Leeds General Infirmary, Leeds, UK, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1.6014905,
                    53.7460006
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Safety/Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife\u00ae-LDP) for Lumbar Discogenic Pain",
                "aff": "Xuanwu Hospital Capital Medical University, Beijing, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT04104412",
                "enrolled": 242,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 87, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2019-01-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116.3912757,
                    39.906217
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)",
                "aff": "The First Hospital of Lanzhou University, Lanzhou, Gansu, China",
                "url": "https://ClinicalTrials.gov/show/NCT05224960",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 83, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2022-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    103.9179183985219,
                    36.0417119
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)",
                "aff": "Hainan hospital of Chinese PLA General Hospital, Sanya, Hainan, China",
                "url": "https://ClinicalTrials.gov/show/NCT05224960",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 83, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2022-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    109.5034392,
                    18.2534658
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)",
                "aff": "Jin Yin-tan hospital, Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT05224960",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 83, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2022-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114.2999353,
                    30.5951051
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)",
                "aff": "Renmin Hospital of Wuhan University, Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT05224960",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 83, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2022-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114.2999353,
                    30.5951051
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)",
                "aff": "Shanghai Changzheng Hospital, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT05224960",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 83, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2022-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.46296160350906,
                    31.23403925
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)",
                "aff": "Beijing 302 Hospital, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT05224960",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 83, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2022-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116.3912757,
                    39.906217
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis",
                "aff": "The First Hospital of Lanzhou University, Lanzhou, Gansu, China",
                "url": "https://ClinicalTrials.gov/show/NCT05121870",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 76, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2021-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    103.9179183985219,
                    36.0417119
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis",
                "aff": "Hainan hospital of Chinese PLA General Hospital, Sanya, Hainan, China",
                "url": "https://ClinicalTrials.gov/show/NCT05121870",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 76, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2021-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    109.5034392,
                    18.2534658
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis",
                "aff": "Renmin Hospital of Wuhan University, Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT05121870",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 76, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2021-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114.2999353,
                    30.5951051
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis",
                "aff": "Shanghai Changzheng Hospital, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT05121870",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 76, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2021-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.46296160350906,
                    31.23403925
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis",
                "aff": "Beijing 302 Hospital, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT05121870",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 76, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2021-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116.3912757,
                    39.906217
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSCs for Prevention of MI-induced HF",
                "aff": "Faghihi Hospital, Shiraz, Fars, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05043610",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 66, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2021-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    54.5643516,
                    32.6475314
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSCs for Prevention of MI-induced HF",
                "aff": "Namazee Hospital, Shiraz, Fars, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05043610",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 66, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2021-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    54.5643516,
                    32.6475314
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Mercy Gilbert Medical Center / Catholic Health Care West, Gilbert, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111.7890373,
                    33.3527632
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Arizona, Tucson, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -110.951744125426,
                    32.2356427
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "UC Davis Medical Center, Sacramento, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -121.493895,
                    38.5810606
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of California - San Diego (UCSD), San Diego, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.23112468377349,
                    32.87924375
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Mount Sinai Medical Center, Miami Beach, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.14087344557441,
                    25.81338075
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.27870688083459,
                    25.71727245
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.66910060446992,
                    41.87352605
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "The Care Group, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.1583502,
                    39.7683331
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91.5299106,
                    41.6612561
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Cotton-O'Neil Clinical Research Center, Topeka, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.677556,
                    39.049011
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Maryland Hospital, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.62461428102453,
                    39.28795845
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Tufts Medical Center, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.06308467518953,
                    42.349439700000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Baystate Medical Center, Springfield, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72.60300615153007,
                    42.12152205
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "UMass Memorial Medical Center, Worcester, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.78967731415291,
                    42.285242
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "William Beaumont Hospital, Royal Oak, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.19410267979237,
                    42.5150439
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Michigan Cardiovascular Institute, Saginaw, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.9490365,
                    43.4200387
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Minneapolis Heart Institute, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93.26112110540949,
                    44.95249955
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74.4518173,
                    40.4862174
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University at Buffalo - Buffalo General Hospital, Buffalo, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.8783922,
                    42.8867166
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Stony Brook University Medical Center, Stony Brook, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.140943,
                    40.9256538
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.2440518,
                    36.0998131
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "The Lindner Research Center, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.5124602,
                    39.1014537
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "The Ohio State University Medical Center, Columbus, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.01873232331297,
                    39.9950822
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Oregon Health & Science University, Portland, Oregon, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.68649573676775,
                    45.4981929
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Penn State University - Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.67321279234645,
                    40.2653862
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Drexel University College of Medicine, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.16467887210737,
                    39.95673585
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Allegheny General Hospital, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.0033113928861,
                    40.45696955
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "The Stern Cardiovascular Center, Germantown, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89.8100858,
                    35.0867577
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Austin Heart P.A., Austin, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97.7436995,
                    30.2711286
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Texas Health Science Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.4031517,
                    29.7029914
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Fletcher Allen Health Care, Burlington, Vermont, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.18869989999999,
                    44.473342900000006
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Wisconsin School of Medicine, Madison, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89.3837613,
                    43.074761
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "McGill University Health Centre, Montreal, Quebec, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 85, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.5999506480536,
                    45.47401605
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis",
                "aff": "Beijing 302 Hospital, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT03945487",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 73, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2019-05-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116.3912757,
                    39.906217
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke",
                "aff": "Department of Neurology, General Hospital of Northern Theater Command, Shenyang, China",
                "url": "https://ClinicalTrials.gov/show/NCT04811651",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 86, 49)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-03-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    123.458674,
                    41.6749893
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum Augsburg, Klinik f\u00fcr Dermatologie und Allergologie, Campus S\u00fcd, Augsburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10.8986971,
                    48.3668041
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Fachklinik Bad Bentheim, Dermatologische Ambulanz, Bad Bentheim, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7.1605921,
                    52.3024786
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Franziskus-Krankenhaus Berlin, Klinik f\u00fcr Innere Medizin, Angiologie und Diabetologie, Berlin, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13.3888599,
                    52.5170365
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Helios Klinikum Berlin-Buch, Klinik f\u00fcr Plastische und \u00c4sthetische Chirurgie, Berlin, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13.3888599,
                    52.5170365
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Helios Klinikum Emil von Behring, Klinik f\u00fcr Plastische und \u00c4sthetische Chirurgie, Berlin, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13.3888599,
                    52.5170365
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Hautarztpraxis Dr. Niesmann & Dr. Othlinghaus, Hautzentrum im Jahrhunderthaus, Bochum, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7.2196635,
                    51.4818111
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Katholisches Klinikum Bochum gGmbH, Venenzentrum der Kliniken f\u00fcr Dermatologie und Gef\u00e4\u00dfchirurgie der Ruhr-Universit\u00e4t Bochum, Bochum, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7.2196635,
                    51.4818111
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Haut\u00e4rzte Braunschweig am Altstadtmarkt, Haut\u00e4rztliche Gemeinschaftspraxis, Braunschweig, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10.5236066,
                    52.2646577
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Klinikum Bremerhaven Reinkenheide gGmbH, Klinik f\u00fcr Dermatologie, Allergologie und Phlebologie, Wundzentrum, Bremerhaven, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8.5851945,
                    53.5505392
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Klinische Forschung Dresden GmbH, Dresden, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13.7381437,
                    51.0493286
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum \"Carl Gustav Carus\" der Technischen Universit\u00e4t Dresden, Medizinische Klinik und Poliklinik III Angiologie und Gef\u00e4\u00dfzentrum, Dresden, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13.7381437,
                    51.0493286
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum D\u00fcsseldorf, Heinrich-Heine-Universit\u00e4t D\u00fcsseldorf, Klinik f\u00fcr Dermatologie, D\u00fcsseldorf, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10.4478313,
                    51.1638175
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum Erlangen, Hautklinik - Wundzentrum Dermatologie, Erlangen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11.0056,
                    49.5928616
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum Essen, Klinik und Poliklinik f\u00fcr Dermatologie, Venerologie und Allergologie, Essen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7.0158171,
                    51.4582235
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum Freiburg, Klinik f\u00fcr Dermatologie und Venerologie, Freiburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7.8494005,
                    47.9960901
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Marienhospital Gelsenkirchen GmbH, Klinik f\u00fcr Chirurgie (Allgemein-, Viszeral- und Endokrine Chirurgie, Thorax-, Gef\u00e4\u00df- und Endovaskul\u00e4re Chirurgie und Kinderchirurgie), Gelsenkirchen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7.0960124,
                    51.5110321
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "SRH Wald-Klinikum Gera GmbH, Zentrum f\u00fcr Klinische Studien, Gera, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12.0796208,
                    50.8772301
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Praxis Dr. med. Abdou Zarzour, Halle, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11.9705452,
                    51.4825041
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum Hamburg- Eppendorf, Institut f\u00fcr Versorgungsforschung in der Dermatologie und bei Pflegeberufen (IVDP), Hamburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10.000654,
                    53.550341
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "MVZ Prof. Dr. Ockenfels, Haut und Allergie-Praxisklinik GmbH, Hanau, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8.918817903264163,
                    50.1354291
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "SRH Klinikum Karlsbad- Langensteinbach GmbH, Interdisziplin\u00e4res Gef\u00e4\u00dfzentrum Innere Medizin, Karlsbad, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8.5088293,
                    48.9038411
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Medizinisches Versorgungszentrum DermaKiel GmbH, Kiel, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10.135555,
                    54.3227085
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Helios Klinikum Krefeld, Klinik f\u00fcr Dermatologie und Venerologie, Krefeld, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    6.5623343,
                    51.3331205
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Hautarztpraxis Langenau, Studienzentrum, Langenau, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10.1222024,
                    48.4975016
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum Leipzig A\u00f6R, Klinik und Poliklinik f\u00fcr Dermatologie, Venerologie und Allergologie, Leipzig, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12.3747329,
                    51.3406321
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Studienambulanz Dr. Schubert Leipzig, Leipzig, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12.3747329,
                    51.3406321
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Diabetologikum Ludwigshafen, die Praxis am Ludwigsplatz, Ludwigshafen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8.4452781,
                    49.484834
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Beldio Research GmbH, Memmingen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10.181319,
                    47.9867696
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Klinikum der Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Klinik und Poliklinik f\u00fcr Dermatologie und Allergologie, M\u00fcnchen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10.4478313,
                    51.1638175
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Dermazentrum M\u00fcnchen, Standort Neuhausen, Studienzentrum, M\u00fcnchen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10.4478313,
                    51.1638175
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum M\u00fcnster, Klinik f\u00fcr Hautkrankheiten, Allgemeine Dermatologie und Venerologie, M\u00fcnster, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10.4478313,
                    51.1638175
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Klinikum N\u00fcrnberg Nord, Klinik f\u00fcr Dermatologie, N\u00fcrnberg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10.4478313,
                    51.1638175
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Hautarztpraxis Prof. Dr. med. Khusru Asadullah, Potsdam, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13.0591397,
                    52.4009309
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Caritas-Krankenhaus St. Josef, Klinik f\u00fcr Plastische und \u00c4sthetische, Hand- und Wiederherstellungschirurgie, Regensburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12.0974869,
                    49.0195333
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsmedizin Rostock, Klinik und Poliklinik f\u00fcr Dermatologie und Venerologie, Rostock, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12.1286127,
                    54.0924445
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Helios Kliniken Schwerin, Plastische, Rekonstruktive und \u00c4sthetische Chirurgie, Schwerin, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11.4148038,
                    53.6288297
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Haut\u00e4rztliche Gemeinschaftspraxis Dr. Leitz und Kollegen, Stuttgart, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9.1800132,
                    48.7784485
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum T\u00fcbingen, Universit\u00e4ts-Hautklinik T\u00fcbingen, T\u00fcbingen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7.9885332,
                    52.2025617
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Helios Universit\u00e4tsklinikum Wuppertal, Zentrums f\u00fcr Dermatologie, Allergologie und Dermatochirurgie, Wuppertal, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7.1780374,
                    51.264018
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum W\u00fcrzburg, Klinik und Poliklinik f\u00fcr Dermatologie, Venerologie und Allergologie, W\u00fcrzburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 99, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-01-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10.4478313,
                    51.1638175
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Alabama Birmingham (UAB) Hospital, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.8024326,
                    33.5206824
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "UCLA Medical Center, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.445498,
                    34.0655633
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of California Medical Center, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.4574026768062,
                    37.76307
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Rocky Mountain Cancer Center, Denver, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -104.96563217321044,
                    39.74521575
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Florida, Gainesville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.34901329340119,
                    29.6328784
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Emory University, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.32778960627682,
                    33.795867650000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Northside Hospital, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.35450682100918,
                    33.9102901
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Northwestern Center for Clinical Research, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.6244212,
                    41.8755616
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.66910060446992,
                    41.87352605
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Chicago Hospitals, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.60488420632774,
                    41.7904074
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Loyola University Medical Center, Maywood, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.83524274972845,
                    41.85901495
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Indiana University Cancer Center, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.1583502,
                    39.7683331
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "St. Francis Cancer Center, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.1583502,
                    39.7683331
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Louisville, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85.75770751081866,
                    38.21332235
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Tufts New England Medical Center, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.060511,
                    42.3554334
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.06875296664998,
                    42.36286045
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Dana Farber Cancer Institute, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.10769331557015,
                    42.33762635
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.10970567673255,
                    42.33837185
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.0466403,
                    42.3315509
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Mayo Medical Center, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92.4630182,
                    44.0234387
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Mississippi Medical Center, Jackson, Mississippi, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.1725205723653,
                    32.32938955
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Kansas City Cancer Center, Lee's Summit, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94.3821295,
                    38.9107156
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Washington University School of Medicine, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.25886733971312,
                    38.6360711
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Roswell Park Cancer Institute, Buffalo, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.8783922,
                    42.8867166
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Memorial Sloan Kettering Cancer Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.95695491103503,
                    40.7644418
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Mount Sinai School of Medicine, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "New York Presbyterian Hospital, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of North Carolina Hospitals, Chapel Hill, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.05578,
                    35.9131542
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Duke University Health System, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.9018053,
                    35.996653
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.2440518,
                    36.0998131
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Jewish Hospital, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.49969939578145,
                    39.13742135
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Ohio State University, Columbus, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.02866465596318,
                    40.00570905
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.67321279234645,
                    40.2653862
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Abramson Cancer Center, University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.1635262,
                    39.9527237
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Thomas Jefferson University, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.15805656266755,
                    39.9489114
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.94609007817003,
                    40.4612409
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Oncology Hematology Association, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.6243098,
                    40.3693889
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Pittsburgh Cancer Centers, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.6243098,
                    40.3693889
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Medical University of South Carolina(MUSC), Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.9402728,
                    32.7876012
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Baylor University Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.78199034999996,
                    32.7865443
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "MD Anderson Cancer Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.39782993506569,
                    29.7076703
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Texas Transplant Institute, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98.4951405,
                    29.4246002
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Virginia Commonwealth University, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.45406089907547,
                    37.54612465
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Fred Hutchinson Cancer Research Center, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.33067301841714,
                    47.6277525
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Medical College of Wisconsin, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88.02245316747553,
                    43.04386705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Adelaide Hospital, Adelaide, South Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    138.58717276889342,
                    -34.9205767
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Melbourne Hospital, Parkville, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    144.9559783,
                    -37.7994515
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Perth Hospital, Perth, Western Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    115.86593154993494,
                    -31.95323205
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "St. Vincent's Hospital, Darlinghurst, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    151.2211881,
                    -33.8792689
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Brisbane Hospital, Herston, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    153.02681090546656,
                    -27.4477301
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Peter Lougheed Centre, Calgary, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -113.9845622352017,
                    51.079522100000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Ottawa Hospital, Ottawa, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.72059219183689,
                    45.39147405
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Princess Margaret Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 82, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.39064248533157,
                    43.65816355
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cells as First-line Treatment for Patients With Acute Graft Versus Host Disease",
                "aff": "Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, Tianjin, China",
                "url": "https://ClinicalTrials.gov/show/NCT05531266",
                "enrolled": 182,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 49)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2022-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    117.1951073,
                    39.0856735
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD)",
                "aff": "Obstetrics and Gynecology Hospital of Fudan University, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT03645525",
                "enrolled": 180,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 95, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2019-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4452993,
                    31.4015684
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD)",
                "aff": "Children's Hospital of Fudan University, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT03645525",
                "enrolled": 180,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 95, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2019-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4452993,
                    31.4015684
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD)",
                "aff": "Shanghai First Maternity and Infant Hospital, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT03645525",
                "enrolled": 180,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 95, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2019-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4452993,
                    31.4015684
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers.",
                "aff": "Korea University Kuro Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03370874",
                "enrolled": 164,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 73, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2018-07-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intracoronary Human Wharton's Jelly- Derived Mesenchymal Stem Cells (WJ-MSCs) Transfer in Patients With Acute Myocardial Infarction (AMI)",
                "aff": "Fu Cheng Lu 6, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT01291329",
                "enrolled": 160,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 76, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2011-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116.2802866,
                    39.9228674
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency",
                "aff": "Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam",
                "url": "https://ClinicalTrials.gov/show/NCT05345418",
                "enrolled": 158,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 82, 55)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2022-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    105.8544441,
                    21.0294498
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Soffer Health Institute, Aventura, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 103, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2017-07-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.1392121,
                    25.9564812
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Clinical Research of South Florida, Coral Gables, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 103, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2017-07-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.2683838,
                    25.72149
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Clinical Physiology Associates, Fort Myers, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 103, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2017-07-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.8723084,
                    26.640628
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Panax Clinical Research, Miami Lakes, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 103, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2017-07-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.3086619,
                    25.9087056
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Miami VA Healthcare System, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 103, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2017-07-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Vista Health Research, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 103, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2017-07-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Advanced Research for Health Improvement, LLC, Naples, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 103, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2017-07-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.80231377307933,
                    26.21044935
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy",
                "aff": "Stanford University, Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04476901",
                "enrolled": 136,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 106, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12979,
                "paneLabel": "pane12979",
                "start": "2021-05-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.16936535498309,
                    37.43131385
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy",
                "aff": "University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04476901",
                "enrolled": 136,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 106, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12979,
                "paneLabel": "pane12979",
                "start": "2021-05-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy",
                "aff": "University of Louisville, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04476901",
                "enrolled": 136,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 106, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12979,
                "paneLabel": "pane12979",
                "start": "2021-05-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85.75770751081866,
                    38.21332235
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy",
                "aff": "Texas Heart Institute, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04476901",
                "enrolled": 136,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 106, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12979,
                "paneLabel": "pane12979",
                "start": "2021-05-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.399419,
                    29.7079305
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of UC-MSCs for the Treatment of Steroid-resistant aGVHD Following Allo-HSCT",
                "aff": "Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT04738981",
                "enrolled": 130,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 62, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12979,
                "paneLabel": "pane12979",
                "start": "2021-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116.3912757,
                    39.906217
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST)",
                "aff": "Belfast Health and Social Care Trust, Royal Hospitals, Belfast, Northern Ireland, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT03042143",
                "enrolled": 129,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 99, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12979,
                "paneLabel": "pane12979",
                "start": "2019-01-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5.9557889,
                    54.5952266
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS",
                "aff": "Helen Keller Hospital, Sheffield, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04493242",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 97, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2020-08-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.70076056923517,
                    34.746119
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS",
                "aff": "St. Joseph Hospital Heritage, Fullerton, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04493242",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 97, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2020-08-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.9294165,
                    33.8708215
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS",
                "aff": "Donald Guthrie Foundation/ Robert Packer Hospital, Sayre, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04493242",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 97, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2020-08-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.515499,
                    41.9789631
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS",
                "aff": "Covenant Health, Lubbock, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04493242",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 97, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2020-08-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -101.94088845989316,
                    33.607761350000004
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS",
                "aff": "PRX Research, Mesquite, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04493242",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 97, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2020-08-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.599472,
                    32.7666103
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars",
                "aff": "Maternal and Child Health Hospital of Foshan, Foshan, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT02968459",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 78, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2021-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113.1159558,
                    23.0239788
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients",
                "aff": "Gang Li, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04093336",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 62, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2019-01-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.3989967,
                    31.2748685
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)",
                "aff": "The John Paul II Hospital, Cracovia, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03418233",
                "enrolled": 115,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 79, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2018-04-19",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    19.9368564,
                    50.0619474
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)",
                "aff": "The University Hospital in Cracow, Cracovia, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03418233",
                "enrolled": 115,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 79, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2018-04-19",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    19.9368564,
                    50.0619474
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)",
                "aff": "Instytut Kardiologii im. Prymasa Tysi\u0105clecia Stefana Kardyna\u0142a Wyszy\u0144skiego, Katowice, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03418233",
                "enrolled": 115,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 79, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2018-04-19",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    19.0215852,
                    50.2598987
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)",
                "aff": "Leszek Giec Upper-Silesian Medical Centre of the Silesian Medical University in Katowice, Katowice, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03418233",
                "enrolled": 115,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 79, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2018-04-19",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    19.0215852,
                    50.2598987
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)",
                "aff": "Central Clinical Hospital of the MSWiA in Warsaw, Warsaw, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03418233",
                "enrolled": 115,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 79, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2018-04-19",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    21.0067249,
                    52.2319581
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis",
                "aff": "China-Japan Friendship Hospital, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT04208646",
                "enrolled": 108,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 76, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2020-05-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116.3912757,
                    39.906217
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis",
                "aff": "The Second Affiliated hospital of Zhejiang University School of Medicine, Hangzhou, China",
                "url": "https://ClinicalTrials.gov/show/NCT04208646",
                "enrolled": 108,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 76, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2020-05-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120.2052342,
                    30.2489634
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis",
                "aff": "Huashan Hospital Affiliated to Fudan University, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04208646",
                "enrolled": 108,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 76, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2020-05-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4692071,
                    31.2322758
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis",
                "aff": "Shanghai General Hospital, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04208646",
                "enrolled": 108,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 76, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2020-05-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.22177867067153,
                    31.0427014
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis",
                "aff": "Shanghai Jiaotong University School of Medicine, Renji Hospital, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04208646",
                "enrolled": 108,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 76, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2020-05-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.47948814597764,
                    31.235586150000003
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis",
                "aff": "Shanghai Sixth People's Hospital, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04208646",
                "enrolled": 108,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 76, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2020-05-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.41788315057596,
                    31.18040725
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis",
                "aff": "Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04208646",
                "enrolled": 108,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 76, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2020-05-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4653415,
                    31.213944
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With Acute Myocardial Infarction (AMI)",
                "aff": "The John Paul II Hospital, Cracovia, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03404063",
                "enrolled": 105,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 88, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2017-09-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    19.9368564,
                    50.0619474
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With Acute Myocardial Infarction (AMI)",
                "aff": "Central Clinical Hospital of the MSWiA in Warsaw, Warsaw, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03404063",
                "enrolled": 105,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 88, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2017-09-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    21.0067249,
                    52.2319581
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury",
                "aff": "Gachon University Gil Hospital, Incheon, Gyunggido, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01041001",
                "enrolled": 104,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 87, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2009-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49.132971,
                    55.8215537
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury",
                "aff": "Inha University Hospital, Incheon, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01041001",
                "enrolled": 104,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 87, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2009-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49.132971,
                    55.8215537
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury",
                "aff": "Hanyang University Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01041001",
                "enrolled": 104,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 87, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2009-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury",
                "aff": "Seoul Veterans Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01041001",
                "enrolled": 104,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 87, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2009-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01041001",
                "enrolled": 104,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 87, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2009-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury",
                "aff": "Asan Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01041001",
                "enrolled": 104,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 87, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2009-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury",
                "aff": "Korea University Guro Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01041001",
                "enrolled": 104,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 87, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2009-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury",
                "aff": "Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01041001",
                "enrolled": 104,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 87, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2009-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells to Treat Type 2 Diabetes",
                "aff": "Chinese PLA General Hospital, Beijing, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT02302599",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 99, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2013-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116.3912757,
                    39.906217
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect",
                "aff": "Inha University Hospital, Incheon, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01626677",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 57, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49.132971,
                    55.8215537
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect",
                "aff": "Gachon University Gil Hospital, Incheon, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01626677",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 57, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49.132971,
                    55.8215537
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect",
                "aff": "Kangbuk Samsung Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01626677",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 57, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect",
                "aff": "Hanyang University Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01626677",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 57, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect",
                "aff": "Seoul Veterans Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01626677",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 57, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01626677",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 57, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect",
                "aff": "Gangnam Severance Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01626677",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 57, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect",
                "aff": "Asan Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01626677",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 57, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect",
                "aff": "Korea University Guro Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01626677",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 57, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect",
                "aff": "Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01626677",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 57, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Repeated Subarachnoid Administrations of hUC-MSCs in Treating SCI",
                "aff": "The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT02481440",
                "enrolled": 102,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 75, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2018-03-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113.33571464111392,
                    23.13654195
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM\u00ae) for Osteochondral Lesion of Talus",
                "aff": "Kyunghee University Medical Center, Seoul, Dongdaemun-gu, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04310215",
                "enrolled": 102,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 97, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2020-03-03",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49.132971,
                    55.8215537
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM\u00ae) for Osteochondral Lesion of Talus",
                "aff": "Gangnam Severance Hospital, Seoul, Gangnam-gu, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04310215",
                "enrolled": 102,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 97, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2020-03-03",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49.132971,
                    55.8215537
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM\u00ae) for Osteochondral Lesion of Talus",
                "aff": "Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04310215",
                "enrolled": 102,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 97, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2020-03-03",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49.132971,
                    55.8215537
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM\u00ae) for Osteochondral Lesion of Talus",
                "aff": "Korea University Guro Hospital, Seoul, Guro-gu, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04310215",
                "enrolled": 102,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 97, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2020-03-03",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    126.89037652807453,
                    37.48619975
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM\u00ae) for Osteochondral Lesion of Talus",
                "aff": "Chungnam National University Hospital, Daejeon, Jung-gu, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04310215",
                "enrolled": 102,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 97, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2020-03-03",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    126.9730191332483,
                    37.56688875
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM\u00ae) for Osteochondral Lesion of Talus",
                "aff": "Inha University Hospital, Incheon, Jung-gu, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04310215",
                "enrolled": 102,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 97, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2020-03-03",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    126.9730191332483,
                    37.56688875
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19)",
                "aff": "General Hospital of Central Theater Command, Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT04288102",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2020-03-05",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114.2999353,
                    30.5951051
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19)",
                "aff": "Maternal and Child Hospital of Hubei Province, Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT04288102",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2020-03-05",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114.2999353,
                    30.5951051
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19)",
                "aff": "Wuhan Huoshenshan Hospital, Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT04288102",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2020-03-05",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114.2999353,
                    30.5951051
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress",
                "aff": "Hospital S\u00e3o Rafael S.A. - Instituto D'Or de Pesquisa e Ensino, Salvador, BA, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT04903327",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 106, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2021-10-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -38.4812772,
                    -12.9822499
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress",
                "aff": "Santa Casa de Miseric\u00f3rdia da Bahia (Hospital Santa Izabel), Salvador, BA, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT04903327",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 106, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2021-10-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -38.4812772,
                    -12.9822499
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress",
                "aff": "Saraiva & Berlinger Ltda. - EPP (IPECC), Campinas, SP, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT04903327",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 106, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2021-10-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -47.06083,
                    -22.90556
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress",
                "aff": "CECIP JAU - Centro de Estudos Cl\u00ednicos do Interior Paulista Ltda., Ja\u00fa, SP, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT04903327",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 106, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2021-10-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -47.551446,
                    -22.3825293
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress",
                "aff": "CEMEC - Centro Multidisciplinar de Estudos Cl\u00ednicos Ltda. - EPP, S\u00e3o Bernardo Do Campo, SP, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT04903327",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 106, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2021-10-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -48.4333875,
                    -22.0702705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress",
                "aff": "Impar Servi\u00e7os Hospitalares S/A (Hospital Nove de Julho), S\u00e3o Paulo, SP, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT04903327",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 106, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2021-10-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -46.7060294,
                    -23.5082223
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Advanced Clinical Research Institute, Anaheim, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.911732,
                    33.8347516
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Veteran's Administration Medical Center (does not require vet status), Long Beach, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.191604,
                    33.7690164
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Southern California University Hospital, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.20188823929676,
                    34.0627257
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of California, San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.45825681806237,
                    37.7627257
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Western States Clinical Research, Wheat Ridge, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -105.0772063,
                    39.766098
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Gastroenterology Center of Connecticut, Hamden, Connecticut, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72.8968716,
                    41.3959287
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Clinical Research of West Florida, Clearwater, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.8001026,
                    27.9658533
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Borland-Groover Clinic, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.655651,
                    30.3321838
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Venture Research Institute, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Shafran Gastroenterology Center, Winter Park, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.3510264,
                    28.5977707
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Atlanta Gastroenterology Associates, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.3902644,
                    33.7489924
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Chicago Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.6244212,
                    41.8755616
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Carle Clinic Association, Urbana, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88.207301,
                    40.1117174
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Indiana University Medical Center, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.16382215911352,
                    39.78755735
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Cotton-O'Neil Clinical Research Center, Topeka, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.677556,
                    39.049011
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Kentucky Hospital, Lexington, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.5082097,
                    38.0286002
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Louisville Hospital, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85.74506887135223,
                    38.2483107
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Gulf Coast Research, Baton Rouge, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91.1391153,
                    30.4507936
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "National Institutes of Health, Bethesda, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.1040039652674,
                    39.00001425
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Metropolitan Gastroenterology Group, Chevy Chase, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.0849245,
                    38.9813699
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.06875296664998,
                    42.36286045
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Brigham and Womens Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.060511,
                    42.3554334
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Clinical Pharmacology Study Group, Worcester, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.8018877,
                    42.2625621
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Center for Clinical Studies, Dearborn, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.1763145,
                    42.3222599
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Center for Digestive Health, Troy, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.1499304,
                    42.6055893
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Minnesota Hospital, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93.23144466768856,
                    44.97101265
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "St Louis Center for Clinical Studies, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.2428756,
                    38.6319657
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72.27010183310576,
                    43.67568425
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Gastroenterology Research Associates, Cedar Knolls, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74.448765,
                    40.8220442
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Holy Name Hospital, Teaneck, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74.01060090485666,
                    40.8830725
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Weill Cornell Medical College, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.9549121,
                    40.7647523
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Mount Sinai School of Medicine, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Rochester Institute for Digestive Diseases, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.615214,
                    43.157285
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Rochester General Hospital, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.5882888540516,
                    43.1920427
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University Hospital and Medical Center, Stony Brook, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.140943,
                    40.9256538
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Charlotte Gastroenterology and Hepatology, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.8430827,
                    35.2272086
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Pinehurst Medical Clinic, Pinehurst, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.4679317,
                    35.1946235
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Wake Forest University, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.2781152,
                    36.134335
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Dayton Science Institute, Dayton, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.1916069,
                    39.7589478
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Gastroenterology United of Tulsa, Tulsa, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.9927436,
                    36.1563122
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Options Health Research, Tulsa, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.9927436,
                    36.1563122
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Allegheney Center for Digestive Health, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.6243098,
                    40.3693889
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Pittsburgh, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.96246095144505,
                    40.44415295
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Gastroenterology Center of the Midsouth, Germantown, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89.8100858,
                    35.0867577
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Nashville GI Specialists, Nashville, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.7742984,
                    36.1622767
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Vanderbilt University Medical Center, Nashville, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.80163418092431,
                    36.14092375
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Baylor University Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.78199034999996,
                    32.7865443
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Texas Medical Branch, Galveston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94.77627329985782,
                    29.31201835
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Memorial Hermann Hospital, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.3971077,
                    29.7144958
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Vermont, Burlington, Vermont, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.19414679705882,
                    44.4737365
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Digestive and Liver Disease Specialists, Norfolk, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.2602336,
                    36.8968052
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "McGuire Research Institute, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.43428,
                    37.5385087
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Seattle Gastroenterology Associates, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.330062,
                    47.6038321
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Calgary, Calgary, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -114.1283072,
                    51.0783651
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Alberta Hospital, Edmonton, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -113.52319456480116,
                    53.5206381
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Health Sciences Centre, Winnipeg, Manitoba, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97.15989306350204,
                    49.9039751
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "London Health Sciences Centre, London, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.243372,
                    42.9832406
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Mount Sinai Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.39033976650668,
                    43.657443650000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of UCB and MSCs in Children With CP: ACCeNT-CP",
                "aff": "Duke University Medical Center, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03473301",
                "enrolled": 91,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 73, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2018-04-10",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.93676230303336,
                    36.0095073
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital General de Alicante, Alicante, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 57, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -0.4859102161254462,
                    38.3632372
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Gregorio Mara\u00f1on, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 57, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3.7035825,
                    40.4167047
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 57, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3.7035825,
                    40.4167047
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "La Paz University Hospital, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 57, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3.7035825,
                    40.4167047
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Clinico Universitario Virgen de la Arrixaca, Murcia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 57, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1.1625427931490806,
                    37.93215975
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Clinica Universidad de Navarra, Pamplona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 57, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1.6642959885309303,
                    42.8058167
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Universitario de Salamanca, Salamanca, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 57, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5.6759707297806425,
                    40.96293715
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Victoria Eugenia Cruz Roja Espa\u00f1ola, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 57, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5.9953403,
                    37.3886303
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Universitario La Fe, Valencia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 57, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -0.3904493,
                    39.4837878
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital de Valladolid, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 57, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4.7169108,
                    41.6570882
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis",
                "aff": "Seoul Nation University Bundang Hospital, Gyeonggi-do, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05182034",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2022-02-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.00921616567815,
                    37.23512285
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis",
                "aff": "Gangnam Severance Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05182034",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2022-02-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis",
                "aff": "Korea University Anam Hospita, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05182034",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2022-02-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis",
                "aff": "Seoul National University Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05182034",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2022-02-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis",
                "aff": "Severance Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05182034",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2022-02-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, Delhi, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 87, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77.2098719369258,
                    28.5643603
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Division of Peripheral Vascular and Endovascular Sciences, Medanta - The Medicity, Gurgaon, Haryana, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 87, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77.04034428844223,
                    28.43905715
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Vascular and Endovascular Surgery, M. S. Ramaiah Medical College and Hospitals, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 87, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77.590082,
                    12.9767936
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Peripheral Vascular Surgery, Sri Jayadeva Institute of Cardiovascular Sciences & Research, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 87, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77.590082,
                    12.9767936
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Surgery, KMC, Mangalore, Mangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 87, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    74.8480016484457,
                    12.85885905
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Vascular Surgery, Madras Medical College, Chennai, Tamil Nadu, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 87, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    80.27313464478527,
                    13.079761
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Vascular Surgery, Sri Ramchandra Medical College, Chennai, Tamil Nadu, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 87, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    80.270186,
                    13.0836939
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Vascular Surgery, Stanley Medical College, Chennai, Tamil Nadu, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 87, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    80.28716805763241,
                    13.10609125
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Vascular Surgery, AMRI Hospital, Kolkata, West Bengal, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 87, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    88.3676076,
                    22.5125412
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Nightingale Hospital, Kolkata, West Bengal, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 87, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    88.3515425,
                    22.546022
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia",
                "aff": "Dankook University Hospital, Cheonan, Chung Nam, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03676400",
                "enrolled": 84,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 99, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2018-09-02",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49.132971,
                    55.8215537
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease",
                "aff": "Shaanxi Provincial People's Hospital, Xi Ail, Shaanxi, China",
                "url": "https://ClinicalTrials.gov/show/NCT02445547",
                "enrolled": 82,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 76, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    109.1357285,
                    35.8894105
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction",
                "aff": "St Vincents Hospital, Sydney, New South Wales, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT02709343",
                "enrolled": 82,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 83, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2017-04-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    151.22056400966432,
                    -33.88056765
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction",
                "aff": "The Prince Charles Hospital, Brisbane, Queensland, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT02709343",
                "enrolled": 82,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 83, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2017-04-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    153.0230853672162,
                    -27.388817000000003
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction",
                "aff": "Royal Adelaide Hospital, Adelaide, South Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT02709343",
                "enrolled": 82,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 83, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2017-04-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    138.58717276889342,
                    -34.9205767
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction",
                "aff": "The Alfred Hospital, Melbourne, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT02709343",
                "enrolled": 82,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 83, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2017-04-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    144.9631608,
                    -37.8142176
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction",
                "aff": "Fiona Stanley Hospital, Murdoch, Western Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT02709343",
                "enrolled": 82,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 83, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2017-04-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    115.84766461278814,
                    -32.0695563
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study on Pneumoconiosis Treated With Whole-lung Lavage Combined With Mesenchymal Stem Cells",
                "aff": "First Affiliated Hospital of the Third Military University, PLA (Southwest Hospital), Chongqing, Chongqing, China",
                "url": "https://ClinicalTrials.gov/show/NCT02668068",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 76, 49)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2016-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106.5478767,
                    29.5647398
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study on Pneumoconiosis Treated With Whole-lung Lavage Combined With Mesenchymal Stem Cells",
                "aff": "Nanjing Chest Hosptial, Nanjing, Jiangsu, China",
                "url": "https://ClinicalTrials.gov/show/NCT02668068",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 76, 49)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2016-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    118.7915079,
                    32.0615652
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Injection of Placental Mesenchymal Stem Cell Derived Exosomes for Treatment of Resistant Perianal Fistula in Crohn's Patients",
                "aff": "Division of Colorectal Surgery, Department of Surgery, Tehran University of Medical Sciences, Tehran, Iran, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05499156",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 73, 55)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2022-01-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51.41666085836621,
                    35.7447916
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell and Conditioned Medium for Cerebral Palsy",
                "aff": "Indonesian National Brain Center, Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04314687",
                "enrolled": 78,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 67, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2021-09-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106.827183,
                    -6.1753942
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase \u2161 Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Venous Leg",
                "aff": "Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, Chongqing, China",
                "url": "https://ClinicalTrials.gov/show/NCT05319106",
                "enrolled": 76,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 106, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2022-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106.5478767,
                    29.5647398
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With COVID-19",
                "aff": "China Medical University Hospital, Taichung, Non-US, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT05501418",
                "enrolled": 75,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 97, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2020-01-05",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120.9820179,
                    23.9739374
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "University of California, San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 99, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2010-10-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.45825681806237,
                    37.7627257
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Clinical Research of West Florida, Clearwater, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 99, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2010-10-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.8001026,
                    27.9658533
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Shafran Gastroenterology Center, Winter Park, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 99, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2010-10-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.3510264,
                    28.5977707
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "University of Chicago, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 99, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2010-10-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.60084387193544,
                    41.79139685
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Cotton-O'Neil Clinical Research Center, Topeka, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 99, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2010-10-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.677556,
                    39.049011
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "University of Maryland, Baltimore, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 99, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2010-10-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.62630185349286,
                    39.289447800000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Chevy Chase Clinical Research, Chevy Chase, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 99, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2010-10-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.0849245,
                    38.9813699
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Saint Louis Center for Clinical Research, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 99, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2010-10-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.2428756,
                    38.6319657
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "St. Louis Center for Clinical Studies, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 99, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2010-10-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.2428756,
                    38.6319657
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Dartmouth HItchcock Medical Center, Lebanon, New Hampshire, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 99, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2010-10-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72.27010183310576,
                    43.67568425
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Weill Cornell Medical College, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 99, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2010-10-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.9549121,
                    40.7647523
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Mount Sinai School of Medicine, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 99, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2010-10-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Gastroenterology Center of the Midsouth, PC, Germantown, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 99, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2010-10-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89.8100858,
                    35.0867577
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Vanderbilt University Medical Center, Nashville, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 99, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2010-10-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.80163418092431,
                    36.14092375
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Baylor University Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 99, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2010-10-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.78199034999996,
                    32.7865443
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "McGuire Research Institute, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 99, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2010-10-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.43428,
                    37.5385087
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Royal Adelaide Hospital, Adelaide, South Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 99, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2010-10-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    138.58717276889342,
                    -34.9205767
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Royal Melbourne Hospital, Melbourne, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 99, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2010-10-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    144.9564192,
                    -37.7994568
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "University of Otago, Christchurch, New Zealand",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 99, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2010-10-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    172.6318208,
                    -43.5348592
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Waikato Hospital, Hamilton, New Zealand",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 99, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2010-10-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    175.28295759033938,
                    -37.80537155
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Osteoarthritis",
                "aff": "Pantai Cheras Medical Centre, Kuala Lumpur, Federal territory, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT01448434",
                "enrolled": 72,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 61, 60)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2011-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101.6937436,
                    3.1396189
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Osteoarthritis",
                "aff": "Serdang Hospital, Kuala Lumpur, Selangor, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT01448434",
                "enrolled": 72,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 61, 60)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2011-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101.69325937891328,
                    2.748372
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Osteoarthritis",
                "aff": "KPJ Ampang Puteri Specialist Hospital, Kuala Lumpur, Selangor, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT01448434",
                "enrolled": 72,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 61, 60)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2011-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101.69325937891328,
                    2.748372
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Osteoarthritis",
                "aff": "Selayang Hospital, Kuala Lumpur, Selangor, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT01448434",
                "enrolled": 72,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 61, 60)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2011-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101.69325937891328,
                    2.748372
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)",
                "aff": "Miami VA Healthcare System, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04629105",
                "enrolled": 70,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 98, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2020-07-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)",
                "aff": "University of Maryland Medical Center, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04629105",
                "enrolled": 70,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 98, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2020-07-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.62439437177966,
                    39.28827365
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)",
                "aff": "Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04629105",
                "enrolled": 70,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 98, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2020-07-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.26771223216093,
                    36.08983775
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Chondrochymal\u00ae for Subjects With Knee Osteoarthritis (Knee OA)",
                "aff": "Taipei Veterans General Hospital, Taipei, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT05027581",
                "enrolled": 70,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 106, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2021-08-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.51972186894156,
                    25.1210087
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Effectiveness of Adding Allogenic Stem Cells After Traditional Treatment of Osteochondral Lesions of the Talus",
                "aff": "Universidad de Chile Clinical Hospital, Santiago, Independencia, Chile",
                "url": "https://ClinicalTrials.gov/show/NCT03905824",
                "enrolled": 70,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 87, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2019-01-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -70.6665002964021,
                    -33.4041507
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency",
                "aff": "Reproductive Medicine Center, The affiliated Drum Towel Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China",
                "url": "https://ClinicalTrials.gov/show/NCT05308342",
                "enrolled": 66,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 79, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2019-10-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    118.7915079,
                    32.0615652
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery",
                "aff": "ISCI/University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02065245",
                "enrolled": 65,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 65, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2014-03-03",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers",
                "aff": "University of Southern California, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04497805",
                "enrolled": 64,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 89, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2020-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.28586662125,
                    34.0218833
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of Alabama, Division of Endocrinology & Metabolism, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 90, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.8024326,
                    33.5206824
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Scripps Whittier Diabetes Institute, La Jolla, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 90, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.2740777,
                    32.8401623
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Stanford University, Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 90, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.16936535498309,
                    37.43131385
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of Florida, Gainesville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 90, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.34901329340119,
                    29.6328784
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Diabetes Research Institute, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 90, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.21148042151425,
                    25.78908785
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of Kentucky, Lexington, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 90, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.5048374161113,
                    38.027038
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of Minnesota, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 90, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93.17945580218505,
                    44.9863392
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Desert Endocrinology CRC, Henderson, Nevada, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 90, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -114.9826194,
                    36.0301134
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Nevada Alliance Against Diabetes, Las Vegas, Nevada, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 90, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.148516,
                    36.1672559
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of North Carolina Diabetes Care Center, Chapel Hill, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 90, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.05578,
                    35.9131542
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "American Health Research, Inc., Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 90, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.98533442909053,
                    35.144928300000004
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "The Lindner Clinical Trial Center, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 90, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.5124602,
                    39.1014537
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Providence Health Partners - Center for Clinical Research, Dayton, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 90, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.1916069,
                    39.7589478
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Cumberland Valley Endocrinology, Carlisle, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 90, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.1890783,
                    40.201499
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "AM Diabetes & Endocrinology Center, Bartlett, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 90, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89.8739753,
                    35.2045329
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "The University of Texas Southwestern Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 90, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.7968559,
                    32.7762719
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Optimum Clinical Research, Inc., Salt Lake City, Utah, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 90, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111.95661302627656,
                    40.748542400000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "The Strelitz Diabetes Center, Eastern VA Medical School, Norfolk, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 90, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.2602336,
                    36.8968052
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of Wisconsin Health- West Clinic, Madison, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 90, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89.3837613,
                    43.074761
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Clinical and Transitional Science Institute, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 90, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.922497,
                    43.0349931
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "David Geffen School of Medicine at UCLA, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 81, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-03-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.242766,
                    34.0536909
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 81, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-03-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.3406288,
                    33.8358492
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "American Health Research, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 81, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-03-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.8430827,
                    35.2272086
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "Upstate Pharmaceutical Research, Greenville, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 81, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-03-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.3984882,
                    34.851354
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "Spartanburg Medical Research, Spartanburg, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 81, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-03-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.9320157,
                    34.9498007
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "Vermont Lung Center, University of Vermont, Burlington, Vermont, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 81, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-03-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.19414679705882,
                    44.4737365
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "Clinical Research of South Florida, Coral Gables, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 90, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2016-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.2683838,
                    25.72149
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "Clinical Physiology Associates, Fort Myers, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 90, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2016-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.8723084,
                    26.640628
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 90, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2016-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.27870688083459,
                    25.71727245
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "Vista Health Research, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 90, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2016-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "Johns Hopkins University, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 90, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2016-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.62185357858337,
                    39.33020225
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "Optimal Research LLC, Rockville, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 90, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2016-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.1516844,
                    39.0817985
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS",
                "aff": "Miami Baptist Hospital, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04494386",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 73, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2020-07-23",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.33858857540258,
                    25.68511695
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS",
                "aff": "Sanford Research, Sioux Falls, South Dakota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04494386",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 73, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2020-07-23",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.7307737,
                    43.5488256
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Effect of Implanting Allogenic Cytokines Derived From Human Amniotic Membrane (HAM) and Mesenchymal Stem Cells Derived From Human Umbilical Cord Wharton's Jelly (HUMCWJ) on Pain and Functioning of Knee Osteoarthritis",
                "aff": "Scott Medical Health Center, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03337243",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 64, 15)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2017-10-09",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.6243098,
                    40.3693889
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for the Survivors of Ischemic Stroke Trial (ASSIST)",
                "aff": "Beijing Tiantan Hospital, Capital Medical University, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT04590118",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2021-04-26",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116.349177,
                    39.9124309
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells in Osteoarthritis",
                "aff": "Department of Orthopedics, M. S. Ramaiah Memorial Hospital, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01453738",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 105, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2011-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77.590082,
                    12.9767936
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells in Osteoarthritis",
                "aff": "Department of Orthopedics, Kasturba Medical College, Manipal, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01453738",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 105, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2011-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    74.78913348652112,
                    13.35373435
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells in Osteoarthritis",
                "aff": "Seth G. S. Medical College and KEM Hospital, Mumbai, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01453738",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 105, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2011-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    72.878176,
                    19.0785451
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells in Osteoarthritis",
                "aff": "Jehangir Hospital, Pune, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01453738",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 105, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2011-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    73.87665054967444,
                    18.53034355
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells in Osteoarthritis",
                "aff": "Department of Immunology Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India",
                "url": "https://ClinicalTrials.gov/show/NCT01453738",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 105, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2011-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    80.9346001,
                    26.8381
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure",
                "aff": "Mercy Gilbert Medical Center, Gilbert, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00721045",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111.7515924133052,
                    33.28757155
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure",
                "aff": "University of California, San Diego, La Jolla, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00721045",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.23112468377349,
                    32.87924375
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure",
                "aff": "Minneapolis Heart Institute 920 East 28th St, Suite 300, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00721045",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93.2654692,
                    44.9772995
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure",
                "aff": "UPMC, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00721045",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.9532452563892,
                    40.467201450000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure",
                "aff": "Texas Heart Institue, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00721045",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.3676974,
                    29.7589382
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure",
                "aff": "Swedish Heart and Vascular Institute, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00721045",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 81, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.330062,
                    47.6038321
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment",
                "aff": "Cell Therapy Center, University of Jordan, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT03326505",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 68, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2017-08-25",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35.87338209486857,
                    32.013409249999995
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment",
                "aff": "Cell Therapy Center, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT03326505",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 68, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2017-08-25",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35.9239625,
                    31.9515694
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "University of California San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 71, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2014-03-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.45825681806237,
                    37.7627257
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "Stanford University, Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 71, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2014-03-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.16936535498309,
                    37.43131385
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 71, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2014-03-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.06875296664998,
                    42.36286045
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "University of Minnesota Medical Center, Saint Paul, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 71, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2014-03-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93.0931028,
                    44.9497487
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "Ohio State University, Columbus, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 71, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2014-03-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.02866465596318,
                    40.00570905
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "University of Pittsburgh, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 71, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2014-03-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.96246095144505,
                    40.44415295
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Plan of Ischemic Stroke",
                "aff": "Peking University Third Hospital, Beijin, China",
                "url": "https://ClinicalTrials.gov/show/NCT04953663",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 92, 53)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2021-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    112.5536978,
                    21.8509337
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress",
                "aff": "Teradan Clinical Trials LLC, Brandon, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04905836",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 77, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2021-10-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.2880507720744,
                    27.928464
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress",
                "aff": "Sarasota Memorial Health Care System (SMH), Sarasota, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04905836",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 77, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2021-10-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.5308545,
                    27.3365805
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress",
                "aff": "St Luke's Research, Boise, Idaho, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04905836",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 77, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2021-10-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -116.200886,
                    43.6166163
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress",
                "aff": "St. Luke's Boise, Boise, Idaho, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04905836",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 77, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2021-10-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -116.200886,
                    43.6166163
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress",
                "aff": "Ascension St. John, Tulsa, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04905836",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 77, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2021-10-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.9688643231512,
                    36.1339564
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress",
                "aff": "PRX Research/Dallas Regional Medical Center, Mesquite, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04905836",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 77, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2021-10-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96.599472,
                    32.7666103
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers",
                "aff": "Korea University Guro Hospital, Guro-gu, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02619877",
                "enrolled": 59,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 72, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    126.89037652807453,
                    37.48619975
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers",
                "aff": "Eulji General Hospital, Nowon-Gu, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02619877",
                "enrolled": 59,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 72, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers",
                "aff": "Severance Hospital, Seodaemun-Gu, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02619877",
                "enrolled": 59,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 72, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers",
                "aff": "Asan medical center, Songpa-Gu, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02619877",
                "enrolled": 59,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 72, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Foot Ulcers",
                "aff": "University of Southern California, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03754465",
                "enrolled": 56,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 103, 42)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2019-01-02",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.28586662125,
                    34.0218833
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial",
                "aff": "UC Davis Health, Sacramento, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04652908",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 69, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2021-06-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -121.493895,
                    38.5810606
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Children's Hospital Los Angeles, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 65, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.29008014420512,
                    34.0976912
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Children's Hospital of Orange County, Orange, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 65, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.8660898647464,
                    33.7809052
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "University of California at San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 65, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.419906,
                    37.7790262
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Children's Hospital Colorado Center for Cancer/Blood Disorders, Aurora, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 65, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -104.8309947,
                    39.7405111
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Alfred I. DuPont Hospital for Children of the Nemours Foundation, Wilmington, Delaware, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 65, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.546589,
                    39.7459468
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Miami Children's Research Institute, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 65, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 65, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.6244212,
                    41.8755616
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Children's Hospital of Michigan, Detroit, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 65, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.05478802048023,
                    42.351889
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "University of Mississippi Medical Center, Jackson, Mississippi, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 65, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.1725205723653,
                    32.32938955
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Washington University, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 65, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.258941,
                    38.634807
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Columbia University Medical Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 65, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Memorial Sloan Kettering Cancer Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 65, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.95695491103503,
                    40.7644418
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Albert Einstein College of Medicine, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 65, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.84572204231365,
                    40.85277655
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Duke University Medical Center, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 65, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.93676230303336,
                    36.0095073
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Oregon University, Portland, Oregon, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 65, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.6753224,
                    45.5143904
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 65, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.94714193501349,
                    32.7842965
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Texas Transplant Institute, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 65, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98.4951405,
                    29.4246002
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Virginia Commonwealth University, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 65, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.45406089907547,
                    37.54612465
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Fred Hutchinson Cancer Research, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 65, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.33067301841714,
                    47.6277525
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Medical College of Wisconsin, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 65, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88.02245316747553,
                    43.04386705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A First-in-Human Study of XSTEM-OA in Patients With Knee Osteoarthritis",
                "aff": "Emeritus Research, Camberwell, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT05344157",
                "enrolled": 54,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 93, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2022-06-22",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    145.0740767,
                    -37.8384623
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy of Allogeneic UCMSCs for Treating Large Defects Knee Injury",
                "aff": "Hospital Canselor Tuanku Muhriz Universiti Kebangsaan Malaysia (HCTM-UKM), Bandar Tun Razak, Wilayah Persekutuan Kuala Lumpur, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT05016011",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 92, 36)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2020-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101.71246244415164,
                    3.0896887
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With No-option Critical Limb Ischemia (N-O CLI)",
                "aff": "The John Paul II Hospital, Cracovia, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03423732",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 81, 47)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2018-04-19",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    19.9368564,
                    50.0619474
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With No-option Critical Limb Ischemia (N-O CLI)",
                "aff": "Leszek Giec Upper-Silesian Medical Centre of the Silesian Medical University in Katowice, Katowice, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03423732",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 81, 47)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2018-04-19",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    19.0215852,
                    50.2598987
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord-derived Mesenchymal Stem Cells With Injectable Collagen Scaffold Transplantation for Chronic Ischemic Cardiomyopathy",
                "aff": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China",
                "url": "https://ClinicalTrials.gov/show/NCT02635464",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 92, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    118.7915079,
                    32.0615652
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Efficacy and Safety of Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchymal Stem Cells in Infertile Women With Thin Endometrium or Endometrial Scarring",
                "aff": "Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China",
                "url": "https://ClinicalTrials.gov/show/NCT03592849",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 82, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2018-08-10",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    118.7915079,
                    32.0615652
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of Allogeneic Low Oxygen Mesenchymal Bone Marrow Cells in Subjects With Myocardial Infarction",
                "aff": "National Research Medical Center, Astana, Kazakhstan",
                "url": "https://ClinicalTrials.gov/show/NCT02672267",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 97, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2014-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    71.4306682,
                    51.1282205
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells",
                "aff": "McGill University Health Centre, Montreal, Quebec, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT04869397",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 65, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-06-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.5999506480536,
                    45.47401605
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Pinnacle Research Group, Anniston, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85.8283224,
                    33.6624824
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Arthrocare Arthritis Care and Research PC, Gilbert, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111.7890373,
                    33.3527632
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Triwest Research Associates, El Cajon, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -116.962526,
                    32.7947731
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "UCLA, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.44685070595054,
                    34.070877749999994
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Inland Rheumatology Clinical Trials Incorporated, Upland, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.6483876,
                    34.09751
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Ocala Rheumatology Research Center, Ocala, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.1400923,
                    29.1871986
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Arthritis Center, Palm Harbor, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.75690699742961,
                    28.0856815
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Sarasota Arthritis Research Center, Sarasota, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.5308545,
                    27.3365805
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "McIlwain Medical Group, Tampa, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.458444,
                    27.9477595
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "JHU Arthritis Center Baltimore, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.610759,
                    39.2908816
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Arthritis Treatment Center, Frederick, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.4127562,
                    39.415779
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Reliant Medical Group, Worcester, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.8012739394816,
                    42.29907935
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Mayo Clinic, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92.466607460917,
                    44.0225389
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Office of Ramesh C. Gupta, MD, Fair Lawn, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74.1189924,
                    40.9210399
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "DJL Clinical Research, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.8430827,
                    35.2272086
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Health Research of Oklahoma, Oklahoma City, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97.5170536,
                    35.4729886
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "University of Pittsburgh, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.96246095144505,
                    40.44415295
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "West Tennessee Research Institute, Jackson, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88.8177418,
                    35.6144446
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Accurate Clinical Research, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.3676974,
                    29.7589382
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Texas Arthritis Research Center, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98.4951405,
                    29.4246002
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    151.18145903228103,
                    -33.88963645
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Southern Clinical Research Pty Ltd, Hobart, Tasmania, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    147.3281233,
                    -42.8825088
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Emeritus Research, Malvern, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    145.0350666,
                    -37.8576088
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS",
                "aff": "H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re - APHP, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT04333368",
                "enrolled": 47,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 101, 45)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2020-04-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2.3200410217200766,
                    48.8588897
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS",
                "aff": "H\u00f4pital Europ\u00e9en Georges Pompidou - APHP, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT04333368",
                "enrolled": 47,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 101, 45)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2020-04-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2.3200410217200766,
                    48.8588897
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Exploratory Efficacy Study of NEUROSTEM\u00ae Versus Placebo in Patients With Alzheimer's Disease",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02054208",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 88, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2014-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Chronic Wounds in Diabetic Foot Syndrome With Allogeneic Adipose Derived Mesenchymal Stem Cells",
                "aff": "Medical University of Warsaw, Department of Diabetology and Internal Diseases, Warsaw, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03865394",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 73, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2019-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    21.0067249,
                    52.2319581
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord Mesenchymal Stem Cell(UC-MSC)Delayed Renal Chronic Kidney Disease(CKD3\u30014 )",
                "aff": "Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT05512988",
                "enrolled": 44,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 74, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-04-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114.41184627402748,
                    30.52021715
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Placental Mesenchymal Stem Cells Treatment on Diabetic Foot Ulcer",
                "aff": "National Institute for Drug Clinical Trial, Beijing Tongren Hospital, Capital Medical University, Beijing, Beiijng, China",
                "url": "https://ClinicalTrials.gov/show/NCT04464213",
                "enrolled": 43,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 102, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2020-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    104.999927,
                    35.000074
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients",
                "aff": "Dr. Moewardi General Hospital, Surakarta, Central Java, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05132972",
                "enrolled": 42,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 86, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    110.828448,
                    -7.5692489
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients",
                "aff": "Dr. Hasan Sadikin, Bandung, West Java, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05132972",
                "enrolled": 42,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 86, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    107.6049539,
                    -6.9344694
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients",
                "aff": "Dr. Sardjito General Hospital, Yogyakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05132972",
                "enrolled": 42,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 86, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-01-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    110.36722565020224,
                    -7.977838399999999
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment With Human Umbilical Cord Mesenchymal Stem Cells for Refractory Diabetic Peripheral Neuropathy",
                "aff": "The Central Hospital of Wuhan, Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT05507697",
                "enrolled": 42,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 107, 55)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2022-05-19",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114.2999353,
                    30.5951051
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis",
                "aff": "China Medical University Hospital, Taichung, Non-US, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT05532943",
                "enrolled": 41,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 74, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2022-11-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120.9820179,
                    23.9739374
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease",
                "aff": "John Wayne Cancer Institute @ Providence St. John's Health Center, Santa Monica, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02833792",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 106, 22)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2016-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.4912273,
                    34.0194704
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cell Transplantation in Tibial Closed Diaphyseal Fractures",
                "aff": "Royan Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02140528",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 102, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51.41666085836621,
                    35.7447916
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease",
                "aff": "Vinmec International Hospital Times City, H\u00e0 N\u1ed9i, Hanoi, Vietnam",
                "url": "https://ClinicalTrials.gov/show/NCT04433104",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 105, 55)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2020-06-09",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    105.8544441,
                    21.0294498
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multi-intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Heart Failure With Reduced Ejection Fraction\uff08PRIME-HFrEF Study\uff09",
                "aff": "Heart Failure Department, East Hospital Affiliated to Tongji University, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04992832",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 93, 55)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-07-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4452993,
                    31.4015684
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for the Treatment of COVID-19",
                "aff": "Southern California Hospital at Culver City / Southern California Hospital at Hollywood, Culver City, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04573270",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 101, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2020-04-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.396466,
                    34.0211224
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate and Severe Crohn's Disease",
                "aff": "Shanghai East Hospital, Shanghai, Pudong New Area, China",
                "url": "https://ClinicalTrials.gov/show/NCT05262829",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 105, 49)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2022-02-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.5919989893762,
                    31.24075985
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Therapy for Chronic Kidney Disease",
                "aff": "Mayo Clinic Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04869761",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 96, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-09-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.44479406045171,
                    30.2604657
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Therapy for Chronic Kidney Disease",
                "aff": "Mayo Clinic in Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04869761",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 96, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-09-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92.466607460917,
                    44.0225389
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Centre for Liver Research & Diagnostics, Hyderabad, Andhra Pradesh, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 77, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    78.0267508,
                    15.8142734
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Mediciti Hospital, Hyderabad, Andhra Pradesh, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 77, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    78.0267508,
                    15.8142734
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Manipal Hospital, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 77, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77.5938727,
                    13.0509925
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "KMC Hospital, Mangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 77, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    74.8480016484457,
                    12.85885905
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Institute of liver disease, HPB surgery and transplant Global Hospitals, Mumbai, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 77, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    72.878176,
                    19.0785451
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Bombay Hospital & Medical Research Center, Mumbai, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 77, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    72.878176,
                    19.0785451
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Ruby Hall clinic, Pune, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 77, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    73.87716013420717,
                    18.5336353
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Sahyadri Speciality Hospital, Pune, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 77, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    73.8971383,
                    18.5543086
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "SMS Medical college and Hospital, Jaipur, Rajasthan, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 77, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    75.8189817,
                    26.9154576
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "SGPGI Lucknow, Lucknow, Uttar Pradesh, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 77, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    80.9360624,
                    26.7464155
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19",
                "aff": "BioXcellerator, Medellin, Antioquia-CO, Colombia",
                "url": "https://ClinicalTrials.gov/show/NCT04390152",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 100, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2020-01-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.573553,
                    6.2443382
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19",
                "aff": "Clinical Somer, Rionegro, Antioquia, Colombia",
                "url": "https://ClinicalTrials.gov/show/NCT04390152",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 100, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2020-01-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.3741691,
                    6.1536166
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Randomized Study of Coronary Revascularization Surgery With Injection of WJ-MSCs and Placement of an Epicardial Extracellular Matrix",
                "aff": "Hospital San Vicente Fundaci\u00f3n, Medell\u00edn, Antioquia, Colombia",
                "url": "https://ClinicalTrials.gov/show/NCT04011059",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 69, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2019-07-02",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.5000086,
                    7.0000085
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke",
                "aff": "Mercy Gilbert and Chandler Medical Center, Gilbert, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01297413",
                "enrolled": 38,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 92, 45)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2011-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111.7890373,
                    33.3527632
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke",
                "aff": "University of California Irvine Department of Neurology, Orange, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01297413",
                "enrolled": 38,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 92, 45)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2011-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.8704931,
                    33.7500378
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke",
                "aff": "University of California San Diego Division of Neurological Surgery, San Diego, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01297413",
                "enrolled": 38,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 92, 45)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2011-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.1627728,
                    32.7174202
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Stem Cell Therapy in Patients With Autism",
                "aff": "Shandong Jiaotong Hospital, Jinan, Shandong, China",
                "url": "https://ClinicalTrials.gov/show/NCT01343511",
                "enrolled": 37,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 92, 49)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2009-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    117.1140042,
                    36.6507007
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells",
                "aff": "University Hospital R\u00edo Hortega, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT03673748",
                "enrolled": 36,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 61, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2022-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4.728562,
                    41.6521328
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells",
                "aff": "Yantai Yuhuangding Hospital, Yantai, Shandong, China",
                "url": "https://ClinicalTrials.gov/show/NCT05155657",
                "enrolled": 36,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 92, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2022-06-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.3835314,
                    37.5354004
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease",
                "aff": "Brain Matters Research, Delray Beach, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02600130",
                "enrolled": 33,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 65, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2016-09-10",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.0728201,
                    26.4614625
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease",
                "aff": "University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02600130",
                "enrolled": 33,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 65, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2016-09-10",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease",
                "aff": "Miami Jewish Health, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02600130",
                "enrolled": 33,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 65, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2016-09-10",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19308907007704,
                    25.82314155
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Children's Hospital Los Angeles, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 100, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118.29008014420512,
                    34.0976912
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "CHOC Children's Hospital of Orange County, Orange, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 100, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117.8704931,
                    33.7500378
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "UCSF Benioff Children's Hospital, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 100, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.3896641,
                    37.7647716
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Children's Hospital Colorado Center for Cancer/Blood Disorders, Aurora, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 100, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -104.8309947,
                    39.7405111
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Alfred I. duPont Hospital for Children of the Nemours Foundation, Wilmington, Delaware, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 100, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.546589,
                    39.7459468
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Miami Children's Research Institute, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 100, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 100, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.6244212,
                    41.8755616
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Children's Hospital of Michigan, Detroit, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 100, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83.05478802048023,
                    42.351889
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "University of Mississippi Medical Center, Jackson, Mississippi, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 100, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.1725205723653,
                    32.32938955
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Washington University, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 100, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.258941,
                    38.634807
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Columbia University Medical Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 100, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Memorial Sloan Kettering Cancer Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 100, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.95695491103503,
                    40.7644418
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "The Children's Hospital at Montefiore, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 100, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Duke University Medical Center, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 100, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.93676230303336,
                    36.0095073
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Oregon Health & Science University, Portland, Oregon, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 100, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.68649573676775,
                    45.4981929
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 100, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.94714193501349,
                    32.7842965
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Texas Transplant Institute, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 100, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98.4951405,
                    29.4246002
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Virginia Commonwealth University, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 100, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.45406089907547,
                    37.54612465
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Fred Hutchinson Cancer Center, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 100, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.33067301841714,
                    47.6277525
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Medical College of Wisconsin, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 100, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88.02245316747553,
                    43.04386705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells",
                "aff": "Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus",
                "url": "https://ClinicalTrials.gov/show/NCT04382547",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 77, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-05-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    27.5618225,
                    53.9024716
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Randomized, Parallel Group, Placebo Control, Unicentric, Interventional Study to Assess the Effect of Expanded Human Allogeneic Adipose-derived Mesenchymal Adult Stem Cells on the Human Response to Lipopolysaccharyde in Human Volunteers",
                "aff": "Academic Medical Center, Amsterdam, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT02328612",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 90, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4.956576595884709,
                    52.2924635
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "St. Francis Hospital, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 98, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.1583502,
                    39.7683331
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "Kansas City Cancer Centers - BMT, Kansas City, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 98, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94.5781416,
                    39.100105
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "The Cancer Center at Hackensack University, Hackensack, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 98, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74.0410865,
                    40.8871438
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "Roswell Park Cancer Institute, Buffalo, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 98, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.8783922,
                    42.8867166
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "Mt. Sinai Hospital, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 98, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115.17449463280128,
                    36.1021436
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Rochester, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 98, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.6307297,
                    43.1226985
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "New York Medical College, Valhalla, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 98, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.7751326,
                    41.0748189
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "MD Anderson Cancer Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 98, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.39782993506569,
                    29.7076703
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "Medical College of Wisconsin, FEC, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 98, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.922497,
                    43.0349931
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Biochemical Correction of Severe EB by Allo HSCT and \"Off-the-shelf\" MSCs",
                "aff": "University of Minnesota Masonic Cancer Center and Medical Center, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01033552",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 98, 15)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2010-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93.2654692,
                    44.9772995
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem Cells",
                "aff": "Ankara University Biotechnology Institute, Ankara, T\u00fcrkiye, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT04224207",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 101, 15)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2019-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    34.9249653,
                    38.9597594
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem Cells",
                "aff": "Umut Arslan, Ankara, T\u00fcrkiye, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT04224207",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 101, 15)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2019-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    34.9249653,
                    38.9597594
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis Pilot Study (The POSEIDON-Pilot Study)",
                "aff": "University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01087996",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 63, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2010-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis Pilot Study (The POSEIDON-Pilot Study)",
                "aff": "Johns Hopkins University, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01087996",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 63, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2010-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.62185357858337,
                    39.33020225
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of CVU",
                "aff": "Venenzentrum der Dermatologischen und Gef\u00e4\u00dfchirurgischen Kliniken, Kliniken der Ruhr-Universit\u00e4t Bochum im St. Maria Hilf Krankenhaus, Bochum, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03257098",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 74, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2017-10-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7.2196635,
                    51.4818111
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of CVU",
                "aff": "Universit\u00e4tsklinikum Erlangen, Hautklinik, Erlangen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03257098",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 74, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2017-10-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11.0056,
                    49.5928616
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of CVU",
                "aff": "Klinik und Poliklinik f\u00fcr Hautkrankheiten, Universit\u00e4tsmedizin Greifswald, Greifswald, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03257098",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 74, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2017-10-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13.3815238,
                    54.095791
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of CVU",
                "aff": "Klinische Forschung Hamburg GmbH, Dermatologie / Allergologie, Hamburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03257098",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 74, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2017-10-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10.000654,
                    53.550341
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of CVU",
                "aff": "pro scientia med im Mare Klinikum; Department Klinische Forschung und Entwicklung, Kiel, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03257098",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 74, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2017-10-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10.135555,
                    54.3227085
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of CVU",
                "aff": "Universit\u00e4tsklinikum M\u00fcnster, Klinik f\u00fcr Hautkrankheiten, Allgemeine Dermatologie und Venerologie, M\u00fcnster, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03257098",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 74, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2017-10-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10.4478313,
                    51.1638175
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of CVU",
                "aff": "Klinische Forschung Schwerin GmbH, Schwerin, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03257098",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 74, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2017-10-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11.4148038,
                    53.6288297
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of CVU",
                "aff": "Universit\u00e4tsklinikum Ulm, Klinik f\u00fcr Dermatologie und Allergologie, Ulm, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03257098",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 74, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2017-10-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9.9934336,
                    48.3974003
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of CVU",
                "aff": "Klinik und Poliklinik f\u00fcr Dermatologie, Venerologie und Allergologie, Universit\u00e4tsklinikum W\u00fcrzburg, W\u00fcrzburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03257098",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 74, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2017-10-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10.4478313,
                    51.1638175
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis",
                "aff": "Asan Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02131077",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 85, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis",
                "aff": "Chung-Ang University Hosptal, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02131077",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 85, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis",
                "aff": "Gangnam Severance Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02131077",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 85, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis",
                "aff": "Nanoori hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02131077",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 85, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis",
                "aff": "Samsung medical center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02131077",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 85, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis",
                "aff": "Seoul National University Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02131077",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 85, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Application of hUC-MSCs in Treating Acute Lung Injury: a Single Center Prospective Clinical Research",
                "aff": "SAHZU, Hanzhou, Zhejiang, China",
                "url": "https://ClinicalTrials.gov/show/NCT04951882",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 67, 35)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2021-06-09",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120.37342882420911,
                    30.30806645
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis",
                "aff": "Shepherd Center, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04956744",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 98, 47)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2021-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.39393276705056,
                    33.81010295
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis",
                "aff": "UMass Memorial Medical Center, Worcester, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04956744",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 98, 47)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2021-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.78967731415291,
                    42.285242
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis",
                "aff": "Rocky Mountain MS Clinic, Salt Lake City, Utah, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04956744",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 98, 47)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2021-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111.8867975,
                    40.7596198
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of Umbilical Cord Mesenchymal Stem Cells Infusion for Aging Frailty",
                "aff": "Shanghai East Hospital, Shanghai Tongji University, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04314011",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 87, 42)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4692071,
                    31.2322758
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome",
                "aff": "Nancy University Hospital, Vand\u0153uvre-l\u00e8s-Nancy, France",
                "url": "https://ClinicalTrials.gov/show/NCT04625738",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 103, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-10-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    1.8883335,
                    46.603354
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B Cirrhosis",
                "aff": "Haikou People's Hospital, Haikou, China",
                "url": "https://ClinicalTrials.gov/show/NCT05106972",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 87, 53)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2021-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    110.33717397045623,
                    20.0626929
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19: A Phase II Clinical Trial",
                "aff": "Direct Biologics, Austin, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05125562",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 60, 25)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2022-11-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97.7436995,
                    30.2711286
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety, Tolerability and Efficacy of CYP-006TK in Adults With Diabetic Foot Ulcers",
                "aff": "Central Adelaide Local Health Network, Adelaide, South Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT05165628",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 79, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2022-01-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    138.5999312,
                    -34.9281805
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke",
                "aff": "Hospital Universitario La Paz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04280003",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 57, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2021-01-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3.6872531870474874,
                    40.48144225
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy of WJ-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression Fracture",
                "aff": "CHA University, CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05018637",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 104, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.00921616567815,
                    37.23512285
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes Mellitus",
                "aff": "Shanghai East Hospital, Shanghai Tongji University, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04441658",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 71, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-04-10",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4452993,
                    31.4015684
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells",
                "aff": "Centro Medico Teknon, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01586312",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 71, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2012-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2.123970972001783,
                    41.39143835
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells",
                "aff": "Hospital Clinico Universitario, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01586312",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 71, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2012-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4.718737949587745,
                    41.656005750000006
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis",
                "aff": "GWOXI Stem Cell Applied Technology Co., Ltd., Hsinchu, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT03943576",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 22)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2019-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120.9686833,
                    24.8066333
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study)",
                "aff": "ISCI / University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02013674",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 61, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-02-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Knee Osteoarthritis",
                "aff": "Clinica Universidad de los Andes, Santiago, Chile",
                "url": "https://ClinicalTrials.gov/show/NCT02580695",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 88, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -70.50308926300528,
                    -33.40768165
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic MSC Treatment for Pulmonary Emphysema",
                "aff": "Department of Pulmonology, Leiden University Medical Center, Leiden, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT04918706",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 81, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2019-06-25",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4.4908843,
                    52.1594747
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04776239",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 61, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2021-01-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.27870688083459,
                    25.71727245
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-201 Clinical Trial",
                "aff": "Hallym university Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03183648",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 76, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2016-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy",
                "aff": "Universidad de los Andes, Santiago de Chile, Chile",
                "url": "https://ClinicalTrials.gov/show/NCT01739777",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 61, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2012-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -70.6504502,
                    -33.4377756
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Intractable Common Extensor Tendon Injury Using Mesenchymal Stem Cells (Allo-ASC)",
                "aff": "Seoul National University Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03449082",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 85, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2018-05-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Development of Novel Strategy for Treatment of Anterior Cruciate Ligament (ACL) Injury Using Stem Cell",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02755376",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 66, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression",
                "aff": "The University of Texas Health Science Center at Houston, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03522545",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 91, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2021-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.3676974,
                    29.7589382
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Menstrual Blood Stem Cells in Severe Covid-19",
                "aff": "Avicenna Research Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05019287",
                "enrolled": 29,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 68, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2021-04-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51.41666085836621,
                    35.7447916
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic HUman Mesenchymal Stem Cell InfusioN Versus Placebo in Subjects With Alcohol Use Disorder and Major DepreSsion.",
                "aff": "University of Texas Rio Grande Valley School of Medicine, Harlingen, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03265808",
                "enrolled": 28,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 76, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2018-03-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97.6960599,
                    26.1907543
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Infertility by Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchyma Stem Cells",
                "aff": "Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China",
                "url": "https://ClinicalTrials.gov/show/NCT02313415",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 80, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-10-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    118.7915079,
                    32.0615652
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, C\u00e1diz, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 70, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -8.9156122,
                    42.8734659
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Reina Sof\u00eda, C\u00f3rdoba, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 70, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4.8379791,
                    39.3260685
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Universitario Virgen de las Nieves, Granada, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 70, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3.6071805571518736,
                    37.1929345
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Universitario Virgen Macarena, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 70, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5.986849978407201,
                    37.40675795
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Unversitario Virgen del Roc\u00edo, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 70, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5.9953403,
                    37.3886303
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Nuestra Se\u00f1ora de Valme, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 70, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-04-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5.9953403,
                    37.3886303
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV)",
                "aff": "Hospital Clinico Universitario, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01860417",
                "enrolled": 25,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 98, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2013-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4.718737949587745,
                    41.656005750000006
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV)",
                "aff": "Instituto de Biologia y Genetica Molecular, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01860417",
                "enrolled": 25,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 98, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2013-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4.717452260190187,
                    41.65580325
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord Mesenchymal Stem Cells for Treating HBV Clinical Study",
                "aff": "Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT05442437",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 91, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2019-08-08",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114.34764080085492,
                    30.55630945
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells (Rotator Cuff Tear)",
                "aff": "Seoul National University College of Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02298023",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC)",
                "aff": "Cleveland Clinic, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04543994",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 80, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-10-10",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.61981946090904,
                    41.50217195
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis",
                "aff": "Cleveland Clinic, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04548583",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 64, 55)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-10-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.61981946090904,
                    41.50217195
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause",
                "aff": "Nepean Hospital, Kingswood, New South Wales, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT04537351",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 75, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-01-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    150.713607622434,
                    -33.7595782
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause",
                "aff": "St George Hospital, Kogarah, New South Wales, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT04537351",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 75, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-01-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    151.1340246663942,
                    -33.9671649
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause",
                "aff": "Westmead Hospital, Westmead, New South Wales, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT04537351",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 75, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-01-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    150.9874192670545,
                    -33.8023373
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause",
                "aff": "Footscray Hospital, Footscray, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT04537351",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 75, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-01-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    144.8979361271368,
                    -37.79515745
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause",
                "aff": "Sunshine Hospital, Saint Albans, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT04537351",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 75, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-01-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    144.38194255663967,
                    -38.1780176
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Use of UC-MSCs for COVID-19 Patients",
                "aff": "Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04355728",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 69, 13)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-04-25",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "hUC Mesenchymal Stem Cells (19#iSCLife\u00ae-UT) Therapy for Patients With Thin Endometrial Infertility",
                "aff": "Xiangya Hospital Central South University, Changsha, Hunan, China",
                "url": "https://ClinicalTrials.gov/show/NCT05495711",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 70, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113.2384362,
                    28.1450774
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Wharton\u00b4s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes",
                "aff": "Karolinska Trial Alliance, Fas 1 enheten, Karolinska Universitetssjukhuset Huddinge, Stockholm, Sweden",
                "url": "https://ClinicalTrials.gov/show/NCT03406585",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 89, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-10-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    17.935005691942855,
                    59.22125005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV)",
                "aff": "Hospital Universitario Rio Hortega, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04361942",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 108, 35)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4.713905228348496,
                    41.6296811
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of DFU \"Malum Perforans\"",
                "aff": "Universit\u00e4tsmedizin Greifswald; Klinik und Poliklinik f\u00fcr Hautkrankheiten, Greifswald, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03267784",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 90, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-10-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13.3815238,
                    54.095791
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of DFU \"Malum Perforans\"",
                "aff": "St. Josefskrankenhaus Heidelberg GmbH; Klinische Studienabteilung, Heidelberg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03267784",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 90, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-10-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8.694724,
                    49.4093582
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of DFU \"Malum Perforans\"",
                "aff": "Diabetologikum Raab, Privat\u00e4rztliche Facharztpraxis, Kassel, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03267784",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 90, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-10-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9.4924096,
                    51.3154546
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of DFU \"Malum Perforans\"",
                "aff": "pro scientia med im Mare Klinikum, Department Klinische Forschung und Entwicklung, Kronshagen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03267784",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 90, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-10-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10.0850663,
                    54.3316362
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of DFU \"Malum Perforans\"",
                "aff": "Studienambulanz Leipzig, medamed GmbH, Leipzig, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03267784",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 90, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-10-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12.3747329,
                    51.3406321
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of DFU \"Malum Perforans\"",
                "aff": "Diabetologikum Ludwigshafen, Gemeinschaftspraxis, Ludwigshafen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03267784",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 90, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-10-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8.4379807,
                    49.4848949
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of DFU \"Malum Perforans\"",
                "aff": "Klinik und Poliklinik f\u00fcr Dermatologie, Venerologie und Allergologie, Universit\u00e4tsklinikum W\u00fcrzburg, W\u00fcrzburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03267784",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 90, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-10-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10.4478313,
                    51.1638175
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transplantation of HUC-MSCs With Injectable Collagen Scaffold for POF",
                "aff": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China",
                "url": "https://ClinicalTrials.gov/show/NCT02644447",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 100, 42)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2015-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    118.7915079,
                    32.0615652
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure",
                "aff": "MedStar Washington Hospital Center, Washington, District of Columbia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02467387",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 72, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.0365427,
                    38.8950368
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure",
                "aff": "Emory University Hospital, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02467387",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 72, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.32208292907711,
                    33.792151000000004
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure",
                "aff": "Northwestern University Centers for Heart Failure Therapy, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02467387",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 72, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.6244212,
                    41.8755616
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure",
                "aff": "Stony Brook Heart Institute, Stony Brook, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02467387",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 72, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73.140943,
                    40.9256538
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure",
                "aff": "Hospital of the University of Pennsylvania, Heart Failure and Transplant Program, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02467387",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 72, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.1635262,
                    39.9527237
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)",
                "aff": "University of Florida, Gainesville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04723303",
                "enrolled": 22,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 84, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-09-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82.34901329340119,
                    29.6328784
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy for Knee Osteoarthritis",
                "aff": "Department of Rheumatology,Ren Ji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai,China, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT02641860",
                "enrolled": 22,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 85, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2015-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4836261,
                    31.2473784
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury Subjects",
                "aff": "Hallym university Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02619851",
                "enrolled": 22,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 98, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2015-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose-escalating Therapeutic Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease",
                "aff": "Leiden University Medical Center (LUMC), Leiden, Zuid Holland, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT01144962",
                "enrolled": 21,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2010-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4.4416249,
                    52.1542677
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Fecal Incontinence Using Allogenic-Adipose-derived Mesenchymal Stem Cells: A Prospective, Dose Escalation, Randomized, Placebo-controlled, Parallel-group, Single-blind, Single-center Pilot Study",
                "aff": "Section of Colon and Rectal Surger, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02384499",
                "enrolled": 21,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 59, 35)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord Mesenchymal Stem Cells For the Treatment of Lumbar Disc Degeneration Disease",
                "aff": "Shanghai General Hospital, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04414592",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 59, 42)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.22177867067153,
                    31.0427014
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord Mesenchymal Stem Cells For the Treatment of Lumbar Disc Degeneration Disease",
                "aff": "Shanghai General Hospital, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04414592",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 59, 42)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.22177867067153,
                    31.0427014
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Osteoporosis",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05152381",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 95, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells",
                "aff": "Saint-Louis Hospital, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT02213705",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 93, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-05-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2.367700706209151,
                    48.87382745
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Trigeminal Neuralgia and Peripheral Neuropathy",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05152368",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 105, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for RA",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05003934",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 74, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05018845",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 76, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)",
                "aff": "Kit Bartalos, Liberty, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05387278",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 92, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94.419079,
                    39.246479
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients",
                "aff": "Renmin Hospital of Wuhan University (East Campus), Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT04336254",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 59, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-05-06",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114.2999353,
                    30.5951051
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for TBI",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05018832",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 73, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Parkinson's Disease",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05152394",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 84, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism",
                "aff": "Stem Cell Institute, Panama City, Panama",
                "url": "https://ClinicalTrials.gov/show/NCT02192749",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 65, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.5341802,
                    8.9714493
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Heart Disease",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05147766",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 98, 22)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05147779",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 90, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Heart Failure Using Human Umbilical Cord Mesenchymal Stem Cells(hUC-MSC)",
                "aff": "Shanghai East Hospital, Shanghai Tongji University, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04939077",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 58, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2019-10-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4452993,
                    31.4015684
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Human Umbilical Cord Mesenchymal Stem Cell in Patients With Cirrhosis Due to Hepatitis B (Compensation Stage)",
                "aff": "Renmin Hospital of Wuhan University, Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT05507762",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 77, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-07-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114.2999353,
                    30.5951051
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "UC-MSCs Gel Treatment Difficult Healing of Skin Ulcers",
                "aff": "Chinese PLA General Hospital, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT02685722",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 96, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2012-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116.3912757,
                    39.906217
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease",
                "aff": "The University of Texas Health Science Center at Houston, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02611167",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 75, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95.3676974,
                    29.7589382
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Testicular Injury and Oligospermia",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05158114",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 95, 49)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord Mesenchymal Stem Cells Transplantation for Patients With Decompensated Liver Cirrhosis",
                "aff": "Shanghai Liver Disease Research Center, the Nanjing Military Command (Shanghai 85 Hospital), Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT01342250",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 92, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2010-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4452993,
                    31.4015684
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05016817",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 81, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Parkinson's Disease",
                "aff": "Hebei Newtherapy BIo-Pharma Technology Co., Ltd, Shijiazhuang, Hebei, China",
                "url": "https://ClinicalTrials.gov/show/NCT03550183",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 81, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2018-01-10",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114.5186081550166,
                    37.9217857
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease",
                "aff": "Mayo Clinic Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05362786",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 68, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.44479406045171,
                    30.2604657
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease",
                "aff": "Mayo Clinic Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05362786",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 68, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92.466607460917,
                    44.0225389
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Eye Diseases",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05147701",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 77, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Ossium Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in the Setting of Crohn's Disease",
                "aff": "Cleveland Clinic, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05075811",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 94, 60)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.61981946090904,
                    41.50217195
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord Mesenchymal Stem Cell Transplantation in Articular Cartilage Defect",
                "aff": "The Fifth Affiliated Hospital Immunotherapy center, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT02291926",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 69, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113.2592945,
                    23.1301964
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis",
                "aff": "Stem Cell Institute, Panama City, Panama",
                "url": "https://ClinicalTrials.gov/show/NCT02034188",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 69, 30)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.5341802,
                    8.9714493
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Evaluation of the Effect of Mesenchymal Stem Cells on the Immune System of Patients With ALS",
                "aff": "JST sp. z o.o., Cz\u0119stochowa, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT04651855",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 100, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-11-02",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    19.134422,
                    52.215933
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Diabetes",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05003908",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 96, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intrathecal Injection for ALS",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05003921",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 91, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease",
                "aff": "Hospital Universitario Valle de Hebr\u00f3n, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05521672",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2.1774322,
                    41.3828939
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease",
                "aff": "Hospital Universitario Fundaci\u00f3n Jim\u00e9nez Diaz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05521672",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3.7035825,
                    40.4167047
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease",
                "aff": "Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05521672",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -0.3763353,
                    39.4697065
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for SCI",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05152290",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 95, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI",
                "aff": "Care Hospital, Hyderabad, Andhra Pradesh, India",
                "url": "https://ClinicalTrials.gov/show/NCT00883727",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 75, 53)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2009-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    78.0267508,
                    15.8142734
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI",
                "aff": "SAL Hospital and Medical Institute, Ahmedabad, Gujarat, India",
                "url": "https://ClinicalTrials.gov/show/NCT00883727",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 75, 53)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2009-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    72.5243905388215,
                    23.04947435
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI",
                "aff": "MS Ramaiah Memorial Hospital, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT00883727",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 75, 53)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2009-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77.590082,
                    12.9767936
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI",
                "aff": "Bhagawan Mahaveer Jain Heart Centre, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT00883727",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 75, 53)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2009-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77.590082,
                    12.9767936
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis",
                "aff": "Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam",
                "url": "https://ClinicalTrials.gov/show/NCT05331872",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 66, 36)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    105.8544441,
                    21.0294498
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Aging Frailty",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05018767",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 102, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05147675",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 61, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease",
                "aff": "Federal Research Clinical Center FMBA of Russia, Moscow, Russian Federation",
                "url": "https://ClinicalTrials.gov/show/NCT02594839",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 61, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2013-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    37.6174943,
                    55.7504461
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Ovarian Failure",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05158933",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 102, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05016804",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 79, 13)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.",
                "aff": "PT Prodia StemCell Indonesia, Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05279768",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 58, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106.827183,
                    -6.1753942
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Pulmonary Diseases",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05147688",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Spinal Cord Injuries With (AutoBM-MSCs)vs (WJ-MSCs).",
                "aff": "Cell Therapy Center, University of Jordan, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT04288934",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 61, 36)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-01-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35.87338209486857,
                    32.013409249999995
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Skin Ulcer",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05158127",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 83, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial",
                "aff": "University Hospital La Paz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01678534",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 68, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3.7035825,
                    40.4167047
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.",
                "aff": "Hospital de Jerez de la Frontera., Jerez de la Frontera, C\u00e1diz., Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01222039",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 73, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2010-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -8.9156122,
                    42.8734659
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.",
                "aff": "Hospital Universitario Virgen de las Nieves, Granada., Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01222039",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 73, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2010-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3.6071805571518736,
                    37.1929345
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.",
                "aff": "Hospital Universitario Virgen del Roc\u00edo de Sevilla, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01222039",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 73, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2010-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5.9953403,
                    37.3886303
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.",
                "aff": "Hospital Cl\u00ednico de Valencia, Valencia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01222039",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 73, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2010-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -0.3763353,
                    39.4697065
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells",
                "aff": "University of Illinois, Department of Ophthalmology and Visual Sciences, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04626583",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 96, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-03-05",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.6244212,
                    41.8755616
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa",
                "aff": "Jakarta Eye Center Hospital, Jakarta, DKI Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04315025",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 84, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2018-09-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106.8277658,
                    -6.1875613
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa",
                "aff": "Sardjito Hospital, Yogyakarta, Special Region, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04315025",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 84, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2018-09-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    110.364917,
                    -7.8011945
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of Allergic Rhinitis Therapy by Stem Cells",
                "aff": "Yantai Yuhuangding Hospital, Yantai, Shandong, China",
                "url": "https://ClinicalTrials.gov/show/NCT05151133",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 83, 49)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-06-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.3835314,
                    37.5354004
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cell Therapy for Chronic Traumatic Cervical Incomplete Spinal Cord Injury",
                "aff": "Hospital de Neurorehabilitaci\u00f3 Institut Guttmann, Badalona, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05054803",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 107, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-09-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2.248254,
                    41.4493539
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cell Therapy for Chronic Traumatic Cervical Incomplete Spinal Cord Injury",
                "aff": "Complexo Hospitalario Universitario A Coru\u00f1a (CHUAC), A Coru\u00f1a, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05054803",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 107, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-09-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -8.73668,
                    42.22529
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)",
                "aff": "Shanghai Sixth People's Hospital, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT05468502",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 104, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.41788315057596,
                    31.18040725
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Bone Marrow MSC Therapy for Knee Osteoarthritis",
                "aff": "Taipei Veterans General Hospital, Taipei, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT03589287",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 94, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2018-05-02",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.51972186894156,
                    25.1210087
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis",
                "aff": "Seoul National University Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04976140",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 79, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-11-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis",
                "aff": "Soonchunhyang University Seoul Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04976140",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 79, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-11-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis",
                "aff": "Hanyang University Seoul Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04976140",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 79, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-11-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease",
                "aff": "Taipei Veterans General Hospital, Taipei, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT02336646",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 70, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2015-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.51972186894156,
                    25.1210087
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of Umbilical Cord Mesenchymal Stem Cells Combined With Collagen Scaffold in the Treatment of Thin Endometrium",
                "aff": "Sir Run Run Shaw hopital,School of medicine,Zhejiang University, Hangzhou, China",
                "url": "https://ClinicalTrials.gov/show/NCT03724617",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 42)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2018-09-29",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120.07879105081204,
                    30.2984361
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS)",
                "aff": "Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare., New Taipei City, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT04347967",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 80, 49)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.67991896754116,
                    25.07213425
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease",
                "aff": "Sydney Local Health District, Sydney, New South Wales, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT02923375",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 87, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    151.2082848,
                    -33.8698439
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease",
                "aff": "Royal Adelaide Hospital, Adelaide, South Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT02923375",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 87, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    138.58717276889342,
                    -34.9205767
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease",
                "aff": "NHS Foundation Trust, Bristol, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT02923375",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 87, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -2.5972985,
                    51.4538022
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease",
                "aff": "NHS Trust, Leeds, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT02923375",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 87, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1.5437941,
                    53.7974185
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease",
                "aff": "NHS Foundation Trust, Liverpool, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT02923375",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 87, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -2.9091196623970523,
                    53.5162812
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease",
                "aff": "NHS Foundation Trust, Manchester, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT02923375",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 87, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -2.2252438985110703,
                    53.4288251
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease",
                "aff": "NHS Foundation Trust, Nottingham, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT02923375",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 87, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1.1496461,
                    52.9534193
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Clinica Universitaria de Navarra, Av Pio XII ,36, Pamplona, Navarra, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 95, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2016-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1.6642959885309303,
                    42.8058167
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Hospital Universitario Reina Sof\u00eda, C\u00f3rdoba, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 95, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2016-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4.8379791,
                    39.3260685
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Hospital Cl\u00ednico Universitario Virgen de la Arrixaca, Murcia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 95, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2016-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1.1305431,
                    37.9923795
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Hospital Regional Universitario de M\u00e1laga, M\u00e1laga, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 95, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2016-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4.8379791,
                    39.3260685
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Hospital clinico universitario de salamanca, Salamanca, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 95, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2016-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5.675433931406962,
                    40.96377355
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Virgen del Rocio University Hospital, av. Manuel Siurot s/n, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 95, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2016-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5.9853438,
                    37.3680642
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Regeneration of Posterior Cruciate Ligament Injury Using Hypoxic Conditioned Allogenic Adipose Mesenchymal Stem Cell and Condition Medium",
                "aff": "Sholahuddin Rhatomy, Sleman, Yogyakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04889963",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 101, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    110.38129042693124,
                    -7.6894175
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Non-cardiac Surgery-induced Lung Injury",
                "aff": "Shanghai East Hospital, Shanghai Tongji University, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04996966",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 66, 36)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4692071,
                    31.2322758
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PHASE 1, OPEN-LABEL SAFETY STUDY OF UMBILICAL CORD LINING MESENCHYMAL STEM CELLS (CORLICYTE\u00ae) TO HEAL CHRONIC DIABETIC FOOT ULCERS",
                "aff": "University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04104451",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 84, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2019-10-12",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -104.8386619,
                    39.7446494
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects",
                "aff": "University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02886884",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 84, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-09-20",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.19362,
                    25.7741728
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa",
                "aff": "University of Minnesota, Masonic Cancer Center and Medical Center, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03529877",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 88, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2019-01-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93.2654692,
                    44.9772995
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa",
                "aff": "EB-Haus Austria; Salzburger Landeskliniken (SALK); Paracelsus Medizinische Privatuniversit\u00e4t Salzburg (PMU), Salzburg, Austria",
                "url": "https://ClinicalTrials.gov/show/NCT03529877",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 88, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2019-01-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13.0464806,
                    47.7981346
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa",
                "aff": "H\u00f4pital Saint-Louis; D\u00e9partement de dermatologie, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT03529877",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 88, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2019-01-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2.3200410217200766,
                    48.8588897
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa",
                "aff": "Department of Dermatology, Medical Center-University of Freiburg, Freiburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03529877",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 88, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2019-01-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7.8494005,
                    47.9960901
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa",
                "aff": "King's College London; St John's Institute of Dermatology;, London, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT03529877",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 88, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2019-01-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -0.1276474,
                    51.5073219
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa",
                "aff": "Great Ormond Street Hospital; Dermatology Department, London, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT03529877",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 88, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2019-01-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -0.1276474,
                    51.5073219
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of UC-MSC Transfusion for ACLF Patients",
                "aff": "Ren Ji Hospital, School of Medicine, Shanghai Jiao TongUniversity,, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04822922",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 88, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-08-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.4452993,
                    31.4015684
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation",
                "aff": "Indiana University, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02685098",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 81, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.1769635756136,
                    39.77477735
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Sub-Acute Stroke Infarct",
                "aff": "Gatot Soebroto Hospital, Jakarta Pusat, DKI Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05008588",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 83, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2021-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106.83711442228916,
                    -6.1766593
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Sub-Acute Stroke Infarct",
                "aff": "PT Prodia StemCell Indonesia, Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05008588",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 83, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2021-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106.827183,
                    -6.1753942
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI)",
                "aff": "Mayo Clinic in Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04388761",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 84, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-08-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.44858105666715,
                    30.2588308
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia",
                "aff": "Yunfei Chen, Tianjin, Tianjin, China",
                "url": "https://ClinicalTrials.gov/show/NCT04014166",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 63, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-10-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    117.1951073,
                    39.0856735
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of Bradykinesia",
                "aff": "IMAC Regeneration Center, Paducah, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04385056",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 72, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-11-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88.6000478,
                    37.0833893
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of Bradykinesia",
                "aff": "Ozzie Smith IMAC Regeneration Center, Chesterfield, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04385056",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 72, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-11-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.5643258,
                    38.661953
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of Bradykinesia",
                "aff": "David Price IMAC Regeneration Center, Brentwood, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04385056",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 72, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-11-15",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.7825235,
                    36.0325687
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro",
                "aff": "University Clinical Hospital of Salamanca, Salamanca, Salamanca/Castilla Le\u00f3n, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02104440",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 87, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2013-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5.5918712,
                    42.6102981
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Refractory Acute Graft-Versus-Host Disease by Sequential Infusion of Allogenic Mesenchymal Stem Cell.",
                "aff": "Grupo Espanol de trasplantes hematopoyeticos y terapia celular, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01956903",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 101, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2010-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3.7035825,
                    40.4167047
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Therapy to Improve Burn Wound Healing",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02104713",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 87, 15)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2014-06-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.27870688083459,
                    25.71727245
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Lupus",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05018858",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 82, 53)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2022-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy",
                "aff": "Yan'an Hospital of Kunming City, Kunming, China",
                "url": "https://ClinicalTrials.gov/show/NCT04125329",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    102.8324209,
                    24.8843019
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Intramuscular Injection of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia",
                "aff": "Franziskus-Krankenhaus, Berlin, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT00919958",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 62, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2009-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13.3450563645368,
                    52.5060312
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Wharton\u00b4s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed With Type I Diabetes",
                "aff": "Karolinska Trial Alliance, Fas 1 enheten, Karolinska Universitetssjukhuset Huddinge, Huddinge, Sweden",
                "url": "https://ClinicalTrials.gov/show/NCT03973827",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 97, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-05-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    17.935005691942855,
                    59.22125005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Autism",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05003960",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 77, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2022-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Stroke",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05158101",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 68, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2022-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MS",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05003388",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 85, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2022-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CP",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05018819",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 89, 55)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2022-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IBD",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05003947",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 59, 53)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2022-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61.8448509,
                    17.1184569
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Tolerability Study of Allogeneic Mesenchymal Stem Cell Infusion in Adults With Cystic Fibrosis",
                "aff": "University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02866721",
                "enrolled": 14,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 66, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2016-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.60623680097736,
                    41.5057921
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke",
                "aff": "China Medical University Hospital, Taichung, Non-US, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT04434768",
                "enrolled": 14,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-05-05",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120.9820179,
                    23.9739374
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke",
                "aff": "Tri-Service General Hospital, Taipei City, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT04434768",
                "enrolled": 14,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-05-05",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.5078001,
                    25.0452747
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B",
                "aff": "Cipto Mangunkusumo hospital, Jakarta, DKI Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04357600",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 106, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-05-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106.84674005186504,
                    -6.19720085
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial",
                "aff": "Seoul national University Hospital, Seoul, Jongno-gu, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04339504",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 86, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-04-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49.132971,
                    55.8215537
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate Safety and Explore Efficacy of SMUP-IA-01 in Patients With Knee Osteoarthritis",
                "aff": "Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04037345",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 85, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-09-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49.132971,
                    55.8215537
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Safety and Exploratory Efficacy of CARTISTEM\u00ae, a Cell Therapy Product for Articular Cartilage Defects",
                "aff": "Cartilage Restoration Center; RUSH University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01733186",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 85, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2013-01-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.6244212,
                    41.8755616
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Safety and Exploratory Efficacy of CARTISTEM\u00ae, a Cell Therapy Product for Articular Cartilage Defects",
                "aff": "Cartilage Repair Center; Brigham and Women's Hospital, Chestnut Hill, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01733186",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 85, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2013-01-07",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.1661647,
                    42.3306529
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD",
                "aff": "University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05333029",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 73, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2022-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.6936813,
                    41.4996562
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Tendon Injury Using Mesenchymal Stem Cells",
                "aff": "Seoul National University College of Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01856140",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 102, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2013-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Pericardial Matrix With Mesenchymal Stem Cells for the Treatment of Patients With Infarcted Myocardial Tissue",
                "aff": "Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT03798353",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 77, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-05-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2.2381723732976044,
                    41.4810542
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile Dysfunction",
                "aff": "Universitas Indonesia, Jakarta Pusat, DKI Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04972890",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 102, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-09-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106.84766448412446,
                    -6.19404975
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (CLI)",
                "aff": "Cardiology PC, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00951210",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 97, 13)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2009-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86.8024326,
                    33.5206824
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (CLI)",
                "aff": "Duke University Medical Center, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00951210",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 97, 13)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2009-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.93676230303336,
                    36.0095073
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of PNEUMOSTEM\u00ae in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) - a US Study",
                "aff": "Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02381366",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 63, 49)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2015-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87.66910060446992,
                    41.87352605
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Stem Cells Implantation Combined With Coronary Bypass Grafting in Patients With Ischemic Cardiomyopathy",
                "aff": "AHEPA University Hospital, Thessaloniki, Greece",
                "url": "https://ClinicalTrials.gov/show/NCT01753440",
                "enrolled": 11,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 95, 28)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2012-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    22.9352716,
                    40.6403167
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Prochymal\u00ae for the Salvage of Treatment-Refractory Acute GVHD Patients",
                "aff": "Duke University, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00284986",
                "enrolled": 11,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 82, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2005-10-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78.94422972195878,
                    36.00015569999999
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord",
                "aff": "Saint-Louis Hospital, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT03562065",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 63, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-08-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2.367700706209151,
                    48.87382745
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients",
                "aff": "Leiden University Medical Center, Leiden, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT02387151",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 61, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2015-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4.4908843,
                    52.1594747
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intrathecal Administration of Expanded Wharton's Jelly Mesenchymal Stem Cells in Chronic Traumatic Spinal Cord Injury",
                "aff": "Hospital de Neurorehabilitaci\u00f3 Institut Guttmann, Badalona, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT03003364",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 74, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2016-11-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2.248254,
                    41.4493539
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis",
                "aff": "Department of Gastroenterology; Gulhane Military Medical Academy, Ankara, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT01378182",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 103, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2011-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    32.8540482,
                    39.9207886
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study on Radiation-induced Pulmonary Fibrosis Treated With Clinical Grade Umbilical Cord Mesenchymal Stem Cells",
                "aff": "First Affiliated Hospital of the Third Military University, PLA (Southwest Hospital), Chongqing, Chongqing, China",
                "url": "https://ClinicalTrials.gov/show/NCT02277145",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 105, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2014-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106.5478767,
                    29.5647398
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic BM-MSCs in Patients With Lumbar Facet Arthropathy",
                "aff": "Mayo Clinic in Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04410731",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 105, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-04-28",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.44858105666715,
                    30.2588308
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease",
                "aff": "Li Yu, Shenzhen, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT05152160",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 61, 36)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2021-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114.0545429,
                    22.5445741
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease",
                "aff": "Kansas University Cancer Center, Kansas City, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03158896",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 79, 53)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-07-09",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94.626497,
                    39.1134562
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "hUC Mesenchymal Stem Cells (19#iSCLife\u00ae-CSD) Therapy for Patients With Healing Poor After Uterus Injury",
                "aff": "Xiangya Hospital Central South University, Changsha, Hunan, China",
                "url": "https://ClinicalTrials.gov/show/NCT03386708",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 83, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113.2384362,
                    28.1450774
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars",
                "aff": "Maternal and Child Health Hospital of Foshan, Foshan, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT03181087",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 81, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2021-11-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113.1159558,
                    23.0239788
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias",
                "aff": "Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05286255",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 107, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2022-05-04",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79.94714193501349,
                    32.7842965
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)",
                "aff": "Emory University/Childen's Healthcare of Atlanta, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03525418",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 47)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-02-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.3902644,
                    33.7489924
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)",
                "aff": "University of Maryland Medical Center, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03525418",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 47)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-02-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.62439437177966,
                    39.28827365
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)",
                "aff": "Johns Hopkins University Hospital, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03525418",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 47)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-02-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76.610759,
                    39.2908816
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)",
                "aff": "Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03525418",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 47)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-02-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84.50228846584608,
                    39.14084475
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)",
                "aff": "University of Utah/Heart Center-Primary Children's Hospital, Salt Lake City, Utah, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03525418",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 76, 47)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-02-21",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111.8867975,
                    40.7596198
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease",
                "aff": "Asan Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05042206",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 107, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2021-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Use of Mesenchymal Stem Cells (MSCs) Differentiated Into Neural Stem Cells (NSCs) in People With Parkinson's (PD).",
                "aff": "Cell Therapy Center, University of Jordan, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT03684122",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 105, 19)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35.87338209486857,
                    32.013409249999995
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients",
                "aff": "Hanyang University Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04835883",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 71, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-08-26",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Bone Marrow Mesenchymal Stem Cells for Patients With Interstitial Lung Disease (ILD) & Connective Tissue Disorders (CTD)",
                "aff": "Mayo Clinic in Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03929120",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 103, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-10-05",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.44858105666715,
                    30.2588308
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD",
                "aff": "Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Punjab, Pakistan",
                "url": "https://ClinicalTrials.gov/show/NCT02824653",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 74, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2015-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    73.048136,
                    33.6038766
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth",
                "aff": "Department of Otolaryngology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark",
                "url": "https://ClinicalTrials.gov/show/NCT03874572",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-03-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12.591076889344563,
                    55.65965525
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth",
                "aff": "Department of Otolaryngology, Rigshospitalet, Copenhagen, Denmark",
                "url": "https://ClinicalTrials.gov/show/NCT03874572",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-03-18",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12.566645251517794,
                    55.69658685
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u2122 Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease",
                "aff": "Osiris Clinical Site, Baton Rouge, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00294112",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 65, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2006-03-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91.1391153,
                    30.4507936
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u2122 Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease",
                "aff": "Osiris Clinical Site, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00294112",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 65, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2006-03-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.8430827,
                    35.2272086
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u2122 Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease",
                "aff": "Osiris Clinical Site, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00294112",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 65, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2006-03-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.6243098,
                    40.3693889
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u2122 Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease",
                "aff": "Osiris Clinical Site, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00294112",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 65, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2006-03-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.43428,
                    37.5385087
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Myocardial Infarction",
                "aff": "China Medical University Hospital, Taichung, Non-US, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT04056819",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 108, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-05-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120.9820179,
                    23.9739374
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT00823316",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 59, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2008-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome",
                "aff": "University of California San Francisco Medical Center, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01775774",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.419906,
                    37.7790262
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome",
                "aff": "Stanford University Medical Center, Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01775774",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122.17030545534064,
                    37.4265407
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01775774",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71.06875296664998,
                    42.36286045
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome",
                "aff": "University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01775774",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.6243098,
                    40.3693889
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease",
                "aff": "Yonsei University College of Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02580617",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 100, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2015-04-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19",
                "aff": "Instituto de Medicina Regenerativa, Tijuana, Baja California, Mexico",
                "url": "https://ClinicalTrials.gov/show/NCT04456361",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 107, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-04-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -116.964662,
                    32.5010188
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cellular Immunotherapy for Septic Shock: A Phase I Trial",
                "aff": "The Ottawa Hospital, Ottawa, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT02421484",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 107, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2015-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.64648499814479,
                    45.40180795
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Human Umbilical Cord-Derived Mesenchymal Stem Cells(BC-U001) for Rheumatoid Arthritis",
                "aff": "Peking Union Medical College Hospital (Dongdan campus), Beijing, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT04971980",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 87, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2021-04-12",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116.3912757,
                    39.906217
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1)",
                "aff": "Beijing 302 Hospital, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT05227846",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 96, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2022-03-22",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116.3912757,
                    39.906217
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation",
                "aff": "St. Jude Children's Research Hospital, Memphis, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00705120",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 96, 47)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "1995-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.0422209611228,
                    35.154389550000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants",
                "aff": "National Chen-Kung University Hospital, Tainan City, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT03631420",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 61, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-09-26",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120.2124235,
                    22.9914751
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients",
                "aff": "Site 550: University of Hassanudin/ Dr. Wahidin Sudirohusodo Hospital, Makassar, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04535856",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 61, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-10-14",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    119.4124282,
                    -5.1342962
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia",
                "aff": "The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT04255147",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 59, 42)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2022-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75.64648499814479,
                    45.40180795
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke",
                "aff": "Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare., New Taipei City, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT04097652",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 69, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-11-05",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.67991896754116,
                    25.07213425
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Exploratory Efficacy Study of NEUROSTEM\u00ae in Subjects Who Control Group of NEUROSTEM\u00ae",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04954534",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 97, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2021-07-12",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease",
                "aff": "Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare., New Taipei City, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT04206007",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 94, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-06-11",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.67991896754116,
                    25.07213425
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Evaluation of PNEUMOSTEM\u00ae Treatment in Premature Infants With Bronchopulmonary Dysplasia",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01297205",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 88, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2010-11-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Safety and The Efficacy Evaluation of NEUROSTEM\u00ae-AD in Patients With Alzheimer's Disease",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01297218",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 93, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2011-02-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis",
                "aff": "The Prince Charles Hospital, Brisbane, Queensland, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01385644",
                "enrolled": 8,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 58, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2010-09-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    153.0230853672162,
                    -27.388817000000003
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stromal Therapy of Osteodysplasia After Allogeneic Bone Marrow Transplantation",
                "aff": "St. Jude Children's Research Hospital, Memphis, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00186914",
                "enrolled": 8,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 84, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "1999-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90.0422209611228,
                    35.154389550000005
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of Mild to Moderate ED",
                "aff": "Z Urology, Coral Springs, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02398370",
                "enrolled": 8,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 88, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2013-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.2706044,
                    26.271192
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells in Severe Ocular Chemical Burn",
                "aff": "Saint Louis Hospital, APHP, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT03967275",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 84, 15)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2020-08-09",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2.38288423439227,
                    48.8476119
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease",
                "aff": "Rigshospitalet, Copenhagen, DK, Denmark",
                "url": "https://ClinicalTrials.gov/show/NCT03878628",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 100, 15)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2019-09-16",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12.566645251517794,
                    55.69658685
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis",
                "aff": "Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT03265613",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 86, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2017-08-24",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113.2592945,
                    23.1301964
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis",
                "aff": "Hanyang university hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03174587",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 105, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2017-05-30",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas Patients With Crohn's Disease",
                "aff": "University of Malaya Medical Centre, Kuala Lumpur, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT05039411",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 100, 55)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2022-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101.65403830175345,
                    3.11256105
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem Cells",
                "aff": "Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus",
                "url": "https://ClinicalTrials.gov/show/NCT04184258",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 76, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2019-07-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    27.5618225,
                    53.9024716
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells",
                "aff": "Taipei Veterans General Hospital, Taipei, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT01649687",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 103, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2012-05-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.51972186894156,
                    25.1210087
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Alzheimer's Disease Stem Cells Multiple Infusions",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04040348",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 73, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2019-09-08",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.27870688083459,
                    25.71727245
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for The Treatment of Frailty Syndrome",
                "aff": "Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare., New Taipei City, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT04914403",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 87, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2021-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.67991896754116,
                    25.07213425
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intra-Osseous Co-Transplant of UCB and hMSC",
                "aff": "Case Comprehensive Cancer Center, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02181478",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 66, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2015-07-22",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81.6936813,
                    41.4996562
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA).",
                "aff": "Taipei Medical University Hospital, Taipei, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT04893174",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 66, 60)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2022-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121.5628989637292,
                    25.025523
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Mesenchymal Stem Cell Derived Exosome in Patients With Acute Ischemic Stroke",
                "aff": "Shahid Beheshti University of Medical Sciences, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03384433",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 87, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2019-04-17",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51.41666085836621,
                    35.7447916
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn Wound",
                "aff": "Hallym university Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02394873",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 92, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2015-03-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis",
                "aff": "Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT03745417",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 107, 55)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2021-01-31",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113.2592945,
                    23.1301964
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB",
                "aff": "GangnamSeverance Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04520022",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 70, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2016-09-13",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-101 Clinical Trial",
                "aff": "Hallym university Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03183622",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 101, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2015-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of ALLO-ASC-DFU in the Patients With Diabetic Foot Ulcers",
                "aff": "Asan Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02394886",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 64, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2014-10-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127.10332700284027,
                    37.50771705
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PD",
                "aff": "Z Urology, Coral Springs, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02395029",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 107, 45)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2013-01-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80.2706044,
                    26.271192
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transplantation of Allogeneic MSC in Patients With Pulp Necrosis and Chronic Apical Periodontitis",
                "aff": "Unidad de Terapia Celular del Instituto de Investigaciones Cient\u00edficas, San Antonio de los Altos, Miranda, Venezuela",
                "url": "https://ClinicalTrials.gov/show/NCT04545307",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 99, 42)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2019-10-27",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -66.9665409,
                    10.3751347
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Bone Marrow Stem Cells as a Source of Allogenic Hepatocyte Transplantation in Homozygous Familial Hypercholesterolemia",
                "aff": "Digestive Disease Research Center, Shariati Hospital, North Kargar Ave., Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT00515307",
                "enrolled": 1,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 70, 28)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12989,
                "paneLabel": "pane12989",
                "start": "2007-06-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51.41666085836621,
                    35.7447916
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease",
                "aff": "Children's National Medical Center, Washington, District of Columbia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02150551",
                "enrolled": 1,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 69, 30)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12989,
                "paneLabel": "pane12989",
                "start": "2015-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77.01397879086224,
                    38.927021
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)",
                "aff": "Asthma and Allergy Consultants, Wichita, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02235844",
                "enrolled": 1,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 75, 34)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12989,
                "paneLabel": "pane12989",
                "start": "2014-08-01",
                "end": "2023-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97.3375448,
                    37.6922361
                ]
            }
        }
    ]
}